Douglas Galasko

Title(s)Professor In Residence, Neurosciences
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    A Single Ascending Dose / Multiple Ascending Dose Phase I study of the GSM 776890 in healthy normal subjects
    NIH R01AG070353Feb 1, 2021 - Nov 30, 2023
    Role: Co-Principal Investigator
    Translational Center for Alzheimer's Disease Target and Drug Discovery
    NIH R34AG049646Sep 30, 2014 - Aug 31, 2016
    Role: Principal Investigator
    Biomarkers in Aging, MCI and Alzheimer's Disease
    NIH R01AG023185Sep 30, 2003 - Jul 31, 2009
    Role: Principal Investigator
    Novel Mechanisms of NSAID Action in Alzheimer's Disease
    NIH P01AG020206Apr 1, 2002 - Jun 30, 2015
    Role: Co-Investigator
    Alzheimer's Disease Cooperative Study
    NIH U19AG010483Jul 1, 1997 - Feb 28, 2021
    Role: Co-Investigator
    Age related neurodegenerative diseases in Micronesia
    NIH P01AG014382Mar 1, 1997 - Dec 31, 2009
    Role: Principal Investigator
    Alzheimer's Disease Cooperative Study (ADCS)
    NIH U01AG010483Sep 30, 1991 - Nov 30, 2012
    Role: Co-Investigator
    UCSD Alzheimer's Disease Research Center P50
    NIH P50AG005131Sep 28, 1984 - Mar 31, 2020
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Reliability and Validity of Smartphone Cognitive Testing for Frontotemporal Lobar Degeneration. JAMA Netw Open. 2024 Apr 01; 7(4):e244266. Staffaroni AM, Clark AL, Taylor JC, Heuer HW, Sanderson-Cimino M, Wise AB, Dhanam S, Cobigo Y, Wolf A, Manoochehri M, Forsberg L, Mester C, Rankin KP, Appleby BS, Bayram E, Bozoki A, Clark D, Darby RR, Domoto-Reilly K, Fields JA, Galasko D, Geschwind D, Ghoshal N, Graff-Radford N, Grossman M, Hsiung GY, Huey ED, Jones DT, Lapid MI, Litvan I, Masdeu JC, Massimo L, Mendez MF, Miyagawa T, Pascual B, Pressman P, Ramanan VK, Ramos EM, Rascovsky K, Roberson ED, Tartaglia MC, Wong B, Miller BL, Kornak J, Kremers W, Hassenstab J, Kramer JH, Boeve BF, Rosen HJ, Boxer AL, ALLFTD Consortium. PMID: 38558141; PMCID: PMC10985553.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration. Res Sq. 2024 Mar 28. Saloner R, Staffaroni A, Dammer E, Johnson ECB, Paolillo E, Wise A, Heuer H, Forsberg L, Lago AL, Webb J, Vogel J, Santillo A, Hansson O, Kramer J, Miller B, Li J, Loureiro J, Sivasankaran R, Worringer K, Seyfried N, Yokoyama J, Seeley W, Spina S, Grinberg L, VandeVrede L, Ljubenkov P, Bayram E, Bozoki A, Brushaber D, Considine C, Day G, Dickerson B, Domoto-Reilly K, Faber K, Galasko D, Geschwind D, Ghoshal N, Graff-Radford N, Hales C, Honig L, Hsiung GY, Huey E, Kornak J, Kremers W, Lapid M, Lee S, Litvan I, McMillan C, Mendez M, Miyagawa T, Pantelyat A, Pascual B, Paulson H, Petrucelli L, Pressman P, Ramos E, Rascovsky K, Roberson E, Savica R, Snyder A, Sullivan AC, Tartaglia C, Vandebergh M, Boeve B, Rosen H, Rojas J, Boxer A, Casaletto K. PMID: 38585969; PMCID: PMC10996789.
      View in: PubMed   Mentions:
    3. Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology. Nat Commun. 2024 Mar 23; 15(1):2615. Kac PR, González-Ortiz F, Emeršic A, Dulewicz M, Koutarapu S, Turton M, An Y, Smirnov D, Kulczynska-Przybik A, Varma VR, Ashton NJ, Montoliu-Gaya L, Camporesi E, Winkel I, Paradowski B, Moghekar A, Troncoso JC, Lashley T, Brinkmalm G, Resnick SM, Mroczko B, Kvartsberg H, Gregoric Kramberger M, Hanrieder J, Cucnik S, Harrison P, Zetterberg H, Lewczuk P, Thambisetty M, Rot U, Galasko D, Blennow K, Karikari TK. PMID: 38521766; PMCID: PMC10960791.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with Early Alzheimer's Disease. medRxiv. 2024 Mar 22. Galasko D, Farlow MR, Lucey BP, Honig LS, Elbert D, Bateman R, Momper J, Thomas R, Rissman RA, Pa J, Aslanyan V, Balasubramanian A, West T, Maccecchini M, Feldman HH. PMID: 38562783; PMCID: PMC10984053.
      View in: PubMed   Mentions:
    5. Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies. JAMA. 2024 Mar 20. Gibbons CH, Levine T, Adler C, Bellaire B, Wang N, Stohl J, Agarwal P, Aldridge GM, Barboi A, Evidente VGH, Galasko D, Geschwind MD, Gonzalez-Duarte A, Gil R, Gudesblatt M, Isaacson SH, Kaufmann H, Khemani P, Kumar R, Lamotte G, Liu AJ, McFarland NR, Miglis M, Reynolds A, Sahagian GA, Saint-Hillaire MH, Schwartzbard JB, Singer W, Soileau MJ, Vernino S, Yerstein O, Freeman R. PMID: 38506839; PMCID: PMC10955354.
      View in: PubMed   Mentions:    Fields:    
    6. Association of Structural Forms of 17q21.31 with the Risk of Progressive Supranuclear Palsy and MAPT Sub-haplotypes. medRxiv. 2024 Feb 28. Wang H, Chang TS, Dombroski BA, Cheng PL, Si YQ, Tucci A, Patil V, Valiente-Banuet L, Farrell K, Mclean C, Molina-Porcel L, Alex R, Paul De Deyn P, Le Bastard N, Gearing M, Donker Kaat L, Van Swieten JC, Dopper E, Ghetti BF, Newell KL, Troakes C, G de Yébenes J, Rábano-Gutierrez A, Meller T, Oertel WH, Respondek G, Stamelou M, Arzberger T, Roeber S, Müller U, Hopfner F, Pastor P, Brice A, Durr A, Ber IL, Beach TG, Serrano GE, Hazrati LN, Litvan I, Rademakers R, Ross OA, Galasko D, Boxer AL, Miller BL, Seeley WW, Van Deerlin VM, Lee EB, White CL, Morris HR, de Silva R, Crary JF, Goate AM, Friedman JS, Leung YY, Coppola G, Naj AC, Wang LS, PSP genetics study group, Dickson DW, Höglinger GU, Tzeng JY, Geschwind DH, Schellenberg GD, Lee WP. PMID: 38464214; PMCID: PMC10925353.
      View in: PubMed   Mentions:
    7. Evaluation of ATNPD Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease. Neurology. 2024 Feb; 102(4):e208033. Cousins KAQ, Irwin DJ, Tropea TF, Rhodes E, Phillips J, Chen-Plotkin AS, Brumm MC, Coffey CS, Kang JH, Simuni T, Foroud TM, Toga AW, Tanner CM, Kieburtz KD, Mollenhauer B, Galasko D, Hutten S, Weintraub D, Siderowf AD, Marek K, Poston KL, Shaw LM, Parkinson's Progression Markers Initiative. PMID: 38306599.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Whole-Genome Sequencing Analysis Reveals New Susceptibility Loci and Structural Variants Associated with Progressive Supranuclear Palsy. medRxiv. 2024 Jan 30. Wang H, Chang TS, Dombroski BA, Cheng PL, Patil V, Valiente-Banuet L, Farrell K, Mclean C, Molina-Porcel L, Rajput A, De Deyn PP, Bastard NL, Gearing M, Kaat LD, Swieten JCV, Dopper E, Ghetti BF, Newell KL, Troakes C, de Yébenes JG, Rábano-Gutierrez A, Meller T, Oertel WH, Respondek G, Stamelou M, Arzberger T, Roeber S, Müller U, Hopfner F, Pastor P, Brice A, Durr A, Ber IL, Beach TG, Serrano GE, Hazrati LN, Litvan I, Rademakers R, Ross OA, Galasko D, Boxer AL, Miller BL, Seeley WW, Deerlin VMV, Lee EB, White CL, Morris H, de Silva R, Crary JF, Goate AM, Friedman JS, Leung YY, Coppola G, Naj AC, Wang LS, PSP genetics study group, Dickson DW, Höglinger GU, Schellenberg GD, Geschwind DH, Lee WP. PMID: 38234807; PMCID: PMC10793533.
      View in: PubMed   Mentions:
    9. Analysis of the longitudinal stability of human plasma miRNAs and implications for disease biomarkers. Sci Rep. 2024 01 25; 14(1):2148. Sandau US, Wiedrick JT, McFarland TJ, Galasko DR, Fanning Z, Quinn JF, Saugstad JA. PMID: 38272952; PMCID: PMC10810819.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Lewy body dementia: Overcoming barriers and identifying solutions. Alzheimers Dement. 2024 Mar; 20(3):2298-2308. Agarwal K, Backler W, Bayram E, Bloom L, Boeve BF, Cha JH, Denslow M, Ferman TJ, Galasko D, Galvin JE, Gomperts SN, Irizarry MC, Kantarci K, Kaushik H, Kietlinski M, Koenig A, Leverenz JB, McKeith I, McLean PJ, Montine TJ, Moose SO, O'Brien JT, Panier V, Ramanathan S, Ringel MS, Scholz SW, Small J, Sperling RA, Taylor A, Taylor JP, Ward RA, Witten L, Hyman BT. PMID: 38265159; PMCID: PMC10942666.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Small RNA Changes in Plasma Have Potential for Early Diagnosis of Alzheimer's Disease before Symptom Onset. Cells. 2024 Jan 23; 13(3). Palade J, Alsop E, Courtright-Lim A, Hsieh M, Whitsett TG, Galasko D, Van Keuren-Jensen K. PMID: 38334599; PMCID: PMC10854972.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    12. Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology. medRxiv. 2023 Dec 11. Kac PR, González-Ortiz F, Emeršic A, Dulewicz M, Koutarapu S, Turton M, An Y, Smirnov D, Kulczynska-Przybik A, Varma V, Ashton NJ, Montoliu-Gaya L, Camporesi E, Winkel I, Paradowski B, Moghekar A, Troncoso JC, Brinkmalm G, Resnick SM, Mroczko B, Kvartsberg H, Kramberger MG, Hanrieder J, Cucnik S, Harrison P, Zetterberg H, Lewczuk P, Thambisetty M, Rot U, Galasko D, Blennow K, Karikari TK. PMID: 38168323; PMCID: PMC10760276.
      View in: PubMed   Mentions: 1  
    13. Limitations of the human iPSC-derived neuron model for early-onset Alzheimer's disease. Mol Brain. 2023 Nov 03; 16(1):75. Valdes P, Henry KW, Fitzgerald MQ, Muralidharan K, Caldwell AB, Ramachandran S, Goldstein LSB, Mobley WC, Galasko DR, Subramaniam S. PMID: 37924159; PMCID: PMC10623777.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    14. Author Correction: Enhancing untargeted metabolomics using metadata-based source annotation. Nat Biotechnol. 2023 Nov; 41(11):1656. Gauglitz JM, West KA, Bittremieux W, Williams CL, Weldon KC, Panitchpakdi M, Di Ottavio F, Aceves CM, Brown E, Sikora NC, Jarmusch AK, Martino C, Tripathi A, Meehan MJ, Dorrestein K, Shaffer JP, Coras R, Vargas F, Goldasich LD, Schwartz T, Bryant M, Humphrey G, Johnson AJ, Spengler K, Belda-Ferre P, Diaz E, McDonald D, Zhu Q, Elijah EO, Wang M, Marotz C, Sprecher KE, Vargas-Robles D, Withrow D, Ackermann G, Herrera L, Bradford BJ, Marques LMM, Amaral JG, Silva RM, Veras FP, Cunha TM, Oliveira RDR, Louzada-Junior P, Mills RH, Piotrowski PK, Servetas SL, Da Silva SM, Jones CM, Lin NJ, Lippa KA, Jackson SA, Daouk RK, Galasko D, Dulai PS, Kalashnikova TI, Wittenberg C, Terkeltaub R, Doty MM, Kim JH, Rhee KE, Beauchamp-Walters J, Wright KP, Dominguez-Bello MG, Manary M, Oliveira MF, Boland BS, Lopes NP, Guma M, Swafford AD, Dutton RJ, Knight R, Dorrestein PC. PMID: 37853256.
      View in: PubMed   Mentions: 2     Fields:    
    15. Assessments of the Utilities of CSF NPTX2 for Disease Progression in Cognitively Normal Individuals Who Progress to Clinical MCI and AD. Ann Neurol. 2023 10; 94(4):618-619. Shaw LM, Galasko D. PMID: 37614206.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium. Alzheimers Dement. 2024 Jan; 20(1):549-562. Jain L, Khrestian M, Formica S, Tuason ED, Pillai JA, Rao S, Oguh O, Lippa CF, Lopez OL, Berman SB, Tsuang DW, Zabetian CP, Irwin DJ, Galasko DR, Litvan I, Marder KS, Honig LS, Fleisher JE, Galvin JE, Bozoki AC, Taylor AS, Sabbagh MN, Leverenz JB, Bekris LM. PMID: 37740924; PMCID: PMC10840643.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. The potential clinical value of plasma biomarkers in Alzheimer's disease. Alzheimers Dement. 2023 Dec; 19(12):5805-5816. Blennow K, Galasko D, Perneczky R, Quevenco FC, van der Flier WM, Akinwonmi A, Carboni M, Jethwa A, Suridjan I, Zetterberg H. PMID: 37694991.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Association Between Self- and Proxy-Reported Depression and Quality of Life in Mild-Moderate Alzheimer's Disease. Am J Geriatr Psychiatry. 2024 01; 32(1):58-67. Joe E, Segal-Gidan F, Cummings JL, Galasko D, Tomaszewski Farias S, Johnson DK, Ross L, Yaffe K, Wang X, Schneider LS, Chui H, Ringman JM, California Alzheimer's Disease Center Investigators. PMID: 37827916; PMCID: PMC10843510.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. The MINT Sprint 2.0: A picture naming test for detection of naming impairments in Alzheimer's disease and in preclinical AD. Alzheimers Dement. 2024 Jan; 20(1):112-123. Gollan TH, Garcia DL, Stasenko A, Murillo M, Kim C, Galasko D, Salmon DP. PMID: 37464962; PMCID: PMC10916946.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    20. Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies LRRC4C, LHX5-AS1 and nominates ancestry-specific loci PTPRK , GRB14 , and KIAA0825 as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium. medRxiv. 2023 Jul 08. Rajabli F, Benchek P, Tosto G, Kushch N, Sha J, Bazemore K, Zhu C, Lee WP, Haut J, Hamilton-Nelson KL, Wheeler NR, Zhao Y, Farrell JJ, Grunin MA, Leung YY, Kuksa PP, Li D, Lucio da Fonseca E, Mez JB, Palmer EL, Pillai J, Sherva RM, Song YE, Zhang X, Iqbal T, Pathak O, Valladares O, Kuzma AB, Abner E, Adams PM, Aguirre A, Albert MS, Albin RL, Allen M, Alvarez L, Apostolova LG, Arnold SE, Asthana S, Atwood CS, Ayres G, Baldwin CT, Barber RC, Barnes LL, Barral S, Beach TG, Becker JT, Beecham GW, Beekly D, Benitez BA, Bennett D, Bertelson J, Bird TD, Blacker D, Boeve BF, Bowen JD, Boxer A, Brewer J, Burke JR, Burns JM, Buxbaum JD, Cairns NJ, Cantwell LB, Cao C, Carlson CS, Carlsson CM, Carney RM, Carrasquillo MM, Chasse S, Chesselet MF, Chin NA, Chui HC, Chung J, Craft S, Crane PK, Cribbs DH, Crocco EA, Cruchaga C, Cuccaro ML, Cullum M, Darby E, Davis B, De Jager PL, DeCarli C, DeToledo J, Dick M, Dickson DW, Dombroski BA, Doody RS, Duara R, Ertekin-Taner N, Evans DA, Faber KM, Fairchild TJ, Fallon KB, Fardo DW, Farlow MR, Fernandez-Hernandez V, Ferris S, Foroud TM, Frosch MP, Fulton-Howard B, Galasko DR, Gamboa A, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Goate AM, Grabowski TJ, Graff-Radford NR, Green RC, Growdon JH, Hakonarson H, Hall J, Hamilton RL, Harari O, Hardy J, Harrell LE, Head E, Henderson VW, Hernandez M, Hohman T, Honig LS, Huebinger RM, Huentelman MJ, Hulette CM, Hyman BT, Hynan LS, Ibanez L, Jarvik GP, Jayadev S, Jin LW, Johnson K, Johnson L, Kamboh MI, Karydas AM, Katz MJ, Kauwe JS, Kaye JA, Keene CD, Khaleeq A, Kim R, Knebl J, Kowall NW, Kramer JH, Kukull WA, LaFerla FM, Lah JJ, Larson EB, Lerner A, Leverenz JB, Levey AI, Lieberman AP, Lipton RB, Logue M, Lopez OL, Lunetta KL, Lyketsos CG, Mains D, Margaret FE, Marson DC, Martin ERR, Martiniuk F, Mash DC, Masliah E, Massman P, Masurkar A, McCormick WC, McCurry SM, McDavid AN, McDonough S, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Montine TJ, Monuki ES, Morris JC, Mukherjee S, Myers AJ, Nguyen T, O'Bryant S, Olichney JM, Ory M, Palmer R, Parisi JE, Paulson HL, Pavlik V, Paydarfar D, Perez V, Peskind E, Petersen RC, Pierce A, Polk M, Poon WW, Potter H, Qu L, Quiceno M, Quinn JF, Raj A, Raskind M, Reiman EM, Reisberg B, Reisch JS, Ringman JM, Roberson ED, Rodriguear M, Rogaeva E, Rosen HJ, Rosenberg RN, Royall DR, Sager MA, Sano M, Saykin AJ, Schneider JA, Schneider LS, Seeley WW, Slifer SH, Small S, Smith AG, Smith JP, Sonnen JA, Spina S, St George-Hyslop P, Stern RA, Stevens AB, Strittmatter SM, Sultzer D, Swerdlow RH, Tanzi RE, Tilson JL, Trojanowski JQ, Troncoso JC, Tsuang DW, Van Deerlin VM, van Eldik LJ, Vance JM, Vardarajan BN, Vassar R, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Whitehead PL, Wijsman EM, Wilhelmsen KC, Williams B, Williamson J, Wilms H, Wingo TS, Wisniewski T, Woltjer RL, Woon M, Wright CB, Wu CK, Younkin SG, Yu CE, Yu L, Zhu X, Kunkle BW, Bush WS, Wang LS, Farrer LA, Haines JL, et al. PMID: 37461624; PMCID: PMC10350126.
      View in: PubMed   Mentions:
    21. Alzheimer's Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer's Disease Trajectory and Relationships with Cognitive Function. Viruses. 2023 06 04; 15(6). Sundermann EE, Campbell LM, Villers O, Bondi MW, Gouaux B, Salmon DP, Galasko D, Soontornniyomkij V, Ellis RJ, Moore DJ. PMID: 37376619; PMCID: PMC10305373.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. Tau seeds occur before earliest Alzheimer's changes and are prevalent across neurodegenerative diseases. Acta Neuropathol. 2023 07; 146(1):31-50. Manca M, Standke HG, Browne DF, Huntley ML, Thomas OR, Orrú CD, Hughson AG, Kim Y, Zhang J, Tatsuoka C, Zhu X, Hiniker A, Coughlin DG, Galasko D, Kraus A. PMID: 37154939; PMCID: PMC10261243.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 2023 05; 22(5):407-417. Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, Galasko D, Kieburtz K, Merchant K, Mollenhauer B, Poston KL, Seibyl J, Simuni T, Tanner CM, Weintraub D, Videnovic A, Choi SH, Kurth R, Caspell-Garcia C, Coffey CS, Frasier M, Oliveira LMA, Hutten SJ, Sherer T, Marek K, Soto C, Parkinson's Progression Markers Initiative. PMID: 37059509; PMCID: PMC10627170.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    24. Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study. Mov Disord Clin Pract. 2023 Jun; 10(6):943-955. Weintraub D, Picillo M, Cho HR, Caspell-Garcia C, Blauwendraat C, Brown EG, Chahine LM, Coffey CS, Dobkin RD, Foroud T, Galasko D, Kieburtz K, Marek K, Merchant K, Mollenhauer B, Poston KL, Simuni T, Siderowf A, Singleton A, Seibyl J, Tanner CM, Parkinson's Progression Markers Initiative. PMID: 37332638; PMCID: PMC10272925.
      View in: PubMed   Mentions: 1  
    25. Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2023 07; 50(9):2669-2682. Chen CD, McCullough A, Gordon B, Joseph-Mathurin N, Flores S, McKay NS, Hobbs DA, Hornbeck R, Fagan AM, Cruchaga C, Goate AM, Perrin RJ, Wang G, Li Y, Shi X, Xiong C, Pontecorvo MJ, Klein G, Su Y, Klunk WE, Jack C, Koeppe R, Snider BJ, Berman SB, Roberson ED, Brosch J, Surti G, Jiménez-Velázquez IZ, Galasko D, Honig LS, Brooks WS, Clarnette R, Wallon D, Dubois B, Pariente J, Pasquier F, Sanchez-Valle R, Shcherbinin S, Higgins I, Tunali I, Masters CL, van Dyck CH, Masellis M, Hsiung R, Gauthier S, Salloway S, Clifford DB, Mills S, Supnet-Bell C, McDade E, Bateman RJ, Benzinger TLS, DIAN-TU Study Team. PMID: 37017737; PMCID: PMC10330155.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    26. SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease. Alzheimers Dement. 2023 10; 19(10):4609-4618. Weiner S, Sauer M, Brinkmalm G, Constantinescu J, Constantinescu R, Gomes BF, Becker B, Nellgård B, Dalla K, Galasko D, Zetterberg H, Blennow K, Gobom J. PMID: 36946611.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. Comparison of the telephone-Montreal Cognitive Assessment (T-MoCA) and Telephone Interview for Cognitive Status (TICS) as screening tests for early Alzheimer's disease. Alzheimers Dement. 2023 10; 19(10):4599-4608. Chappelle SD, Gigliotti C, Léger GC, Peavy GM, Jacobs DM, Banks SJ, Little EA, Galasko D, Salmon DP. PMID: 36939111; PMCID: PMC10509307.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration. Brain. 2023 03 01; 146(3):1152-1165. Gonzalez-Ortiz F, Turton M, Kac PR, Smirnov D, Premi E, Ghidoni R, Benussi L, Cantoni V, Saraceno C, Rivolta J, Ashton NJ, Borroni B, Galasko D, Harrison P, Zetterberg H, Blennow K, Karikari TK. PMID: 36572122; PMCID: PMC9976981.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    29. A proteogenomic view of Parkinson's disease causality and heterogeneity. NPJ Parkinsons Dis. 2023 Feb 11; 9(1):24. Kaiser S, Zhang L, Mollenhauer B, Jacob J, Longerich S, Del-Aguila J, Marcus J, Raghavan N, Stone D, Fagboyegun O, Galasko D, Dakna M, Bilican B, Dovlatyan M, Kostikova A, Li J, Peterson B, Rotte M, Sanz V, Foroud T, Hutten SJ, Frasier M, Iwaki H, Singleton A, Marek K, Crawford K, Elwood F, Messa M, Serrano-Fernandez P. PMID: 36774388; PMCID: PMC9922273.
      View in: PubMed   Mentions: 8  
    30. Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panel. Alzheimers Dement (N Y). 2023 Jan-Mar; 9(1):e12375. Sabbagh MN, Taylor A, Galasko D, Galvin JE, Goldman JG, Leverenz JB, Poston KL, Boeve BF, Irwin DJ, Quinn JF. PMID: 36873923; PMCID: PMC9983146.
      View in: PubMed   Mentions: 1  
    31. APOE differentially moderates cerebrospinal fluid and plasma phosphorylated tau181 associations with multi-domain cognition. Neurobiol Aging. 2023 05; 125:1-8. Weigand AJ, Ortiz G, Walker KS, Galasko DR, Bondi MW, Thomas KR, Alzheimer's Disease Neuroimaging Initiative. PMID: 36780762.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression. J Parkinsons Dis. 2023; 13(6):899-916. Brumm MC, Siderowf A, Simuni T, Burghardt E, Choi SH, Caspell-Garcia C, Chahine LM, Mollenhauer B, Foroud T, Galasko D, Merchant K, Arnedo V, Hutten SJ, O'Grady AN, Poston KL, Tanner CM, Weintraub D, Kieburtz K, Marek K, Coffey CS, Parkinson’s Progression Markers Initiative. PMID: 37458046; PMCID: PMC10578214.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Cerebrospinal fluid immune dysregulation during healthy brain aging and cognitive impairment. Cell. 2022 12 22; 185(26):5028-5039.e13. Piehl N, van Olst L, Ramakrishnan A, Teregulova V, Simonton B, Zhang Z, Tapp E, Channappa D, Oh H, Losada PM, Rutledge J, Trelle AN, Mormino EC, Elahi F, Galasko DR, Henderson VW, Wagner AD, Wyss-Coray T, Gate D. PMID: 36516855; PMCID: PMC9815831.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    34. SOBA: Development and testing of a soluble oligomer binding assay for detection of amyloidogenic toxic oligomers. Proc Natl Acad Sci U S A. 2022 12 13; 119(50):e2213157119. Shea D, Colasurdo E, Smith A, Paschall C, Jayadev S, Keene CD, Galasko D, Ko A, Li G, Peskind E, Daggett V. PMID: 36490316; PMCID: PMC9897489.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    35. Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer's disease. Cell Stem Cell. 2022 12 01; 29(12):1637-1652.e6. Herdy JR, Traxler L, Agarwal RK, Karbacher L, Schlachetzki JCM, Boehnke L, Zangwill D, Galasko D, Glass CK, Mertens J, Gage FH. PMID: 36459967; PMCID: PMC10093780.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    36. Lack of Benefit of Iron Chelation in Early Parkinson's Disease. N Engl J Med. 2022 12 01; 387(22):2087-2088. Galasko D, Simuni T. PMID: 36449427.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across Tauopathies. J Neuropathol Exp Neurol. 2022 11 16; 81(12):953-964. Coughlin DG, Hiniker A, Peterson C, Kim Y, Arezoumandan S, Giannini L, Pizzo D, Weintraub D, Siderowf A, Litvan I, Rissman RA, Galasko D, Hansen L, Trojanowski JQ, Lee E, Grossman M, Irwin D. PMID: 36269086; PMCID: PMC9677241.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    38. Sex differences in Alzheimer's disease: plasma MMP-9 and markers of disease severity. Alzheimers Res Ther. 2022 11 02; 14(1):160. Tsiknia AA, Sundermann EE, Reas ET, Edland SD, Brewer JB, Galasko D, Banks SJ, Alzheimer’s Disease Neuroimaging Initiative. PMID: 36324151; PMCID: PMC9628176.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    39. Transcriptomic profiling of sporadic Alzheimer's disease patients. Mol Brain. 2022 10 12; 15(1):83. Caldwell AB, Anantharaman BG, Ramachandran S, Nguyen P, Liu Q, Trinh I, Galasko DR, Desplats PA, Wagner SL, Subramaniam S. PMID: 36224601; PMCID: PMC9559068.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    40. Perception of Fragmented Letters by Patients With Pathologically Confirmed Dementia With Lewy Bodies or Alzheimer Disease. Neurology. 2022 11 01; 99(18):e2034-e2043. Salmon DP, Smirnov DS, Coughlin DG, Hamilton JM, Landy KM, Filoteo JV, Hiniker A, Hansen LA, Galasko D. PMID: 36028327; PMCID: PMC9651460.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    41. Warburg-like metabolic transformation underlies neuronal degeneration in sporadic Alzheimer's disease. Cell Metab. 2022 09 06; 34(9):1248-1263.e6. Traxler L, Herdy JR, Stefanoni D, Eichhorner S, Pelucchi S, Szücs A, Santagostino A, Kim Y, Agarwal RK, Schlachetzki JCM, Glass CK, Lagerwall J, Galasko D, Gage FH, D'Alessandro A, Mertens J. PMID: 35987203; PMCID: PMC9458870.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    42. Selective tau seeding assays and isoform-specific antibodies define neuroanatomic distribution of progressive supranuclear palsy pathology arising in Alzheimer's disease. Acta Neuropathol. 2022 10; 144(4):789-792. Coughlin DG, Goodwill VS, Standke HG, Kim Y, Coley N, Pizzo DP, Galasko D, Kraus A, Hiniker A. PMID: 35980456; PMCID: PMC9467964.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Autocorrection if→of function words in reading aloud: A novel marker of Alzheimer's risk. Neuropsychology. 2023 Oct; 37(7):813-826. Gollan TH, Stasenko A, Li C, Smirnov DS, Galasko D, Salmon DP. PMID: 35925735; PMCID: PMC9898462.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    44. α-Synuclein Seed Amplification in CSF and Brain from Patients with Different Brain Distributions of Pathological α-Synuclein in the Context of Co-Pathology and Non-LBD Diagnoses. Ann Neurol. 2022 10; 92(4):650-662. Arnold MR, Coughlin DG, Brumbach BH, Smirnov DS, Concha-Marambio L, Farris CM, Ma Y, Kim Y, Wilson EN, Kaye JA, Hiniker A, Woltjer RL, Galasko DR, Quinn JF. PMID: 35808984; PMCID: PMC9489647.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    45. TDP-43 Pathology Exacerbates Cognitive Decline in Primary Age-Related Tauopathy. Ann Neurol. 2022 09; 92(3):425-438. Smirnov DS, Salmon DP, Galasko D, Edland SD, Pizzo DP, Goodwill V, Hiniker A. PMID: 35696592; PMCID: PMC9391297.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    46. Enhancing untargeted metabolomics using metadata-based source annotation. Nat Biotechnol. 2022 12; 40(12):1774-1779. Gauglitz JM, West KA, Bittremieux W, Williams CL, Weldon KC, Panitchpakdi M, Di Ottavio F, Aceves CM, Brown E, Sikora NC, Jarmusch AK, Martino C, Tripathi A, Meehan MJ, Dorrestein K, Shaffer JP, Coras R, Vargas F, Goldasich LD, Schwartz T, Bryant M, Humphrey G, Johnson AJ, Spengler K, Belda-Ferre P, Diaz E, McDonald D, Zhu Q, Elijah EO, Wang M, Marotz C, Sprecher KE, Vargas-Robles D, Withrow D, Ackermann G, Herrera L, Bradford BJ, Marques LMM, Amaral JG, Silva RM, Veras FP, Cunha TM, Oliveira RDR, Louzada-Junior P, Mills RH, Piotrowski PK, Servetas SL, Da Silva SM, Jones CM, Lin NJ, Lippa KA, Jackson SA, Daouk RK, Galasko D, Dulai PS, Kalashnikova TI, Wittenberg C, Terkeltaub R, Doty MM, Kim JH, Rhee KE, Beauchamp-Walters J, Wright KP, Dominguez-Bello MG, Manary M, Oliveira MF, Boland BS, Lopes NP, Guma M, Swafford AD, Dutton RJ, Knight R, Dorrestein PC. PMID: 35798960; PMCID: PMC10277029.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    47. Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer's disease. Alzheimers Dement. 2022 Jul 02. Tian C, Stewart T, Hong Z, Guo Z, Aro P, Soltys D, Pan C, Peskind ER, Zabetian CP, Shaw LM, Galasko D, Quinn JF, Shi M, Zhang J, Alzheimer's Disease Neuroimaging Initiative. PMID: 35779041; PMCID: PMC9806186.
      View in: PubMed   Mentions: 16     Fields:    
    48. A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment. Brain. 2022 06 30; 145(6):1924-1938. Levey AI, Qiu D, Zhao L, Hu WT, Duong DM, Higginbotham L, Dammer EB, Seyfried NT, Wingo TS, Hales CM, Gámez Tansey M, Goldstein DS, Abrol A, Calhoun VD, Goldstein FC, Hajjar I, Fagan AM, Galasko D, Edland SD, Hanfelt J, Lah JJ, Weinshenker D. PMID: 34919634; PMCID: PMC9630662.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    49. Sex differences in plasma p-tau181 associations with Alzheimer's disease biomarkers, cognitive decline, and clinical progression. Mol Psychiatry. 2022 10; 27(10):4314-4322. Tsiknia AA, Edland SD, Sundermann EE, Reas ET, Brewer JB, Galasko D, Banks SJ, Alzheimer’s Disease Neuroimaging Initiative. PMID: 35768637; PMCID: PMC9718670.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    50. Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease. Acta Neuropathol Commun. 2022 06 22; 10(1):90. Hall S, Orrù CD, Serrano GE, Galasko D, Hughson AG, Groveman BR, Adler CH, Beach TG, Caughey B, Hansson O. PMID: 35733234; PMCID: PMC9219141.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    51. Proposed research criteria for prodromal behavioural variant frontotemporal dementia. Brain. 2022 04 29; 145(3):1079-1097. Barker MS, Gottesman RT, Manoochehri M, Chapman S, Appleby BS, Brushaber D, Devick KL, Dickerson BC, Domoto-Reilly K, Fields JA, Forsberg LK, Galasko DR, Ghoshal N, Goldman J, Graff-Radford NR, Grossman M, Heuer HW, Hsiung GY, Knopman DS, Kornak J, Litvan I, Mackenzie IR, Masdeu JC, Mendez MF, Pascual B, Staffaroni AM, Tartaglia MC, Boeve BF, Boxer AL, Rosen HJ, Rankin KP, Cosentino S, Rascovsky K, Huey ED, ALLFTD Consortium. PMID: 35349636; PMCID: PMC9050566.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    52. Differential Effects of APOE Genotype on MicroRNA Cargo of Cerebrospinal Fluid Extracellular Vesicles in Females With Alzheimer's Disease Compared to Males. Front Cell Dev Biol. 2022; 10:864022. Sandau US, McFarland TJ, Smith SJ, Galasko DR, Quinn JF, Saugstad JA. PMID: 35573689; PMCID: PMC9092217.
      View in: PubMed   Mentions: 8  
    53. Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders. Cell Rep Med. 2022 04 19; 3(4):100607. Gendron TF, Heckman MG, White LJ, Veire AM, Pedraza O, Burch AR, Bozoki AC, Dickerson BC, Domoto-Reilly K, Foroud T, Forsberg LK, Galasko DR, Ghoshal N, Graff-Radford NR, Grossman M, Heuer HW, Huey ED, Hsiung GR, Irwin DJ, Kaufer DI, Leger GC, Litvan I, Masdeu JC, Mendez MF, Onyike CU, Pascual B, Ritter A, Roberson ED, Rojas JC, Tartaglia MC, Wszolek ZK, Rosen H, Boeve BF, Boxer AL, ALLFTD consortium, Petrucelli L. PMID: 35492244; PMCID: PMC9044101.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    54. The neuroinflammatory marker sTNFR2 relates to worse cognition and tau in women across the Alzheimer's disease spectrum. Alzheimers Dement (Amst). 2022; 14(1):e12284. Bernier RA, Banks SJ, Panizzon MS, Andrews MJ, Jacobs EG, Galasko DR, Shepherd AL, Akassoglou K, Sundermann EE, Alzheimer's Disease Neuroimaging Initiative. PMID: 35386474; PMCID: PMC8973901.
      View in: PubMed   Mentions: 2  
    55. Dynamics of neuroinflammation in Alzheimer's disease. Lancet Neurol. 2022 04; 21(4):297-298. Smirnov D, Galasko D. PMID: 35305329.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    56. Plasma biomarkers for Alzheimer's Disease in relation to neuropathology and cognitive change. Acta Neuropathol. 2022 04; 143(4):487-503. Smirnov DS, Ashton NJ, Blennow K, Zetterberg H, Simrén J, Lantero-Rodriguez J, Karikari TK, Hiniker A, Rissman RA, Salmon DP, Galasko D. PMID: 35195758; PMCID: PMC8960664.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    57. Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium. Front Neurol. 2021; 12:805135. Scott GD, Arnold MR, Beach TG, Gibbons CH, Kanthasamy AG, Lebovitz RM, Lemstra AW, Shaw LM, Teunissen CE, Zetterberg H, Taylor AS, Graham TC, Boeve BF, Gomperts SN, Graff-Radford NR, Moussa C, Poston KL, Rosenthal LS, Sabbagh MN, Walsh RR, Weber MT, Armstrong MJ, Bang JA, Bozoki AC, Domoto-Reilly K, Duda JE, Fleisher JE, Galasko DR, Galvin JE, Goldman JG, Holden SK, Honig LS, Huddleston DE, Leverenz JB, Litvan I, Manning CA, Marder KS, Pantelyat AY, Pelak VS, Scharre DW, Sha SJ, Shill HA, Mari Z, Quinn JF, Irwin DJ. PMID: 35173668; PMCID: PMC8841880.
      View in: PubMed   Mentions: 8  
    58. Endotype reversal as a novel strategy for screening drugs targeting familial Alzheimer's disease. Alzheimers Dement. 2022 Nov; 18(11):2117-2130. Caldwell AB, Liu Q, Zhang C, Schroth GP, Galasko DR, Rynearson KD, Tanzi RE, Yuan SH, Wagner SL, Subramaniam S. PMID: 35084109.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    59. Spillover: The Approval of New Medications for Alzheimer's Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants. J Alzheimers Dis. 2022; 90(3):1035-1043. Mozersky J, Roberts JS, Rumbaugh M, Chhatwal J, Wijsman E, Galasko D, Blacker D, AGREED. PMID: 35404285; PMCID: PMC9794032.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    60. A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time? J Alzheimers Dis. 2022; 90(3):963-966. Galasko DR, Grill JD, Lingler JH, Heidebrink JL, Symptomatic Subcommittee of the Advisory Group on Risk Evidence Education for Dementia (AGREEDementi. PMID: 35147543.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    61. Long-standing multiple system atrophy-Parkinsonism with limbic and FTLD-type α-synuclein pathology. Neuropathol Appl Neurobiol. 2022 04; 48(3):e12783. Coughlin DG, Dryden I, Goodwill VS, Pizzo DP, Wright B, Lessig S, Galasko D, MacKenzie IR, Hiniker A. PMID: 34847258; PMCID: PMC9097824.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    62. NT1-Tau Is Increased in CSF and Plasma of CJD Patients, and Correlates with Disease Progression. Cells. 2021 12 13; 10(12). Mengel D, Mok TH, Nihat A, Liu W, Rissman RA, Galasko D, Zetterberg H, Mead S, Collinge J, Walsh DM. PMID: 34944022; PMCID: PMC8700417.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    63. Association of Neurofibrillary Tangle Distribution With Age at Onset-Related Clinical Heterogeneity in Alzheimer Disease: An Autopsy Study. Neurology. 2022 02 01; 98(5):e506-e517. Smirnov DS, Salmon DP, Galasko D, Goodwill VS, Hansen LA, Zhao Y, Edland SD, Léger GC, Peavy GM, Jacobs DM, Rissman R, Pizzo DP, Hiniker A. PMID: 34810247; PMCID: PMC8826459.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    64. CD4+ T cells contribute to neurodegeneration in Lewy body dementia. Science. 2021 Nov 12; 374(6569):868-874. Gate D, Tapp E, Leventhal O, Shahid M, Nonninger TJ, Yang AC, Strempfl K, Unger MS, Fehlmann T, Oh H, Channappa D, Henderson VW, Keller A, Aigner L, Galasko DR, Davis MM, Poston KL, Wyss-Coray T. PMID: 34648304; PMCID: PMC9122025.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    65. Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease-related declines. Alzheimers Dement (Amst). 2021; 13(1):e12238. Thomas KR, Bangen KJ, Edmonds EC, Weigand AJ, Walker KS, Bondi MW, Galasko DR, Alzheimer's Disease Neuroimaging Initiative. PMID: 34692978; PMCID: PMC8515224.
      View in: PubMed   Mentions: 11  
    66. Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease. PLoS One. 2021; 16(10):e0257372. Bartl M, Dakna M, Galasko D, Hutten SJ, Foroud T, Quan M, Marek K, Siderowf A, Franz J, Trenkwalder C, Mollenhauer B, Parkinson’s Progression Markers Initiative. PMID: 34618817; PMCID: PMC8496858.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    67. A Case of Frontotemporal Lobar Degeneration With FUS-Positive Pathology (FTLD-FET) With Corticobasal Features and Language Deficits. J Neuropathol Exp Neurol. 2021 09 27; 80(9):890-892. Goodwill V, Coughlin D, Pizzo D, Galasko D, Hansen LA, Yuan SH, Hiniker A. PMID: 33969424; PMCID: PMC8476078.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    68. Data-Driven vs Consensus Diagnosis of MCI: Enhanced Sensitivity for Detection of Clinical, Biomarker, and Neuropathologic Outcomes. Neurology. 2021 09 28; 97(13):e1288-e1299. Edmonds EC, Smirnov DS, Thomas KR, Graves LV, Bangen KJ, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW. PMID: 34376506; PMCID: PMC8480404.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    69. Lewy Body Dementia Association's Industry Advisory Council: proceedings of the second annual meeting. Alzheimers Res Ther. 2021 07 08; 13(1):124. Goldman JG, Boeve BF, Armstrong MJ, Galasko DR, Galvin JE, Irwin DJ, Leverenz JB, Marder K, Abler V, Biglan K, Irizarry MC, Keller B, Lai R, Munsie L, Belleville M, Chaney O, Richard I, Taylor A, Graham T. PMID: 34238345; PMCID: PMC8265285.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    70. Arterial stiffening acts synergistically with APOE genotype and AD biomarker status to influence memory in older adults without dementia. Alzheimers Res Ther. 2021 07 01; 13(1):121. Bangen KJ, Smirnov DS, Delano-Wood L, Wierenga CE, Bondi MW, Salmon DP, Galasko D. PMID: 34210365; PMCID: PMC8246656.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    71. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nat Med. 2021 Jul; 27(7):1187-1196. Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ, Hitchcock JM, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, Cruchaga C, Goate AA, Perrin RJ, Xiong C, Li Y, Morris JC, Snider BJ, Mummery C, Surti GM, Hannequin D, Wallon D, Berman SB, Lah JJ, Jimenez-Velazquez IZ, Roberson ED, van Dyck CH, Honig LS, Sánchez-Valle R, Brooks WS, Gauthier S, Galasko DR, Masters CL, Brosch JR, Hsiung GR, Jayadev S, Formaglio M, Masellis M, Clarnette R, Pariente J, Dubois B, Pasquier F, Jack CR, Koeppe R, Snyder PJ, Aisen PS, Thomas RG, Berry SM, Wendelberger BA, Andersen SW, Holdridge KC, Mintun MA, Yaari R, Sims JR, Baudler M, Delmar P, Doody RS, Fontoura P, Giacobino C, Kerchner GA, Bateman RJ, Dominantly Inherited Alzheimer Network–Trials Unit. PMID: 34155411; PMCID: PMC8988051.
      View in: PubMed   Mentions: 100     Fields:    Translation:Humans
    72. Active immunization in Alzheimer's disease. Nat Aging. 2021 06; 1(6):493-495. Galasko D. PMID: 37117835.
      View in: PubMed   Mentions: Translation:HumansPHPublic Health
    73. Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease. Mov Disord. 2021 08; 36(8):1972-1978. Kremer T, Taylor KI, Siebourg-Polster J, Gerken T, Staempfli A, Czech C, Dukart J, Galasko D, Foroud T, Chahine LM, Coffey CS, Simuni T, Weintraub D, Seibyl J, Poston KL, Toga AW, Tanner CM, Marek K, Hutten SJ, Dziadek S, Trenkwalder C, Pagano G, Mollenhauer B. PMID: 33942926; PMCID: PMC8453505.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    74. Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group. Lancet Neurol. 2021 06; 20(6):484-496. Dubois B, Villain N, Frisoni GB, Rabinovici GD, Sabbagh M, Cappa S, Bejanin A, Bombois S, Epelbaum S, Teichmann M, Habert MO, Nordberg A, Blennow K, Galasko D, Stern Y, Rowe CC, Salloway S, Schneider LS, Cummings JL, Feldman HH. PMID: 33933186; PMCID: PMC8339877.
      View in: PubMed   Mentions: 201     Fields:    Translation:Humans
    75. Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer's patients. Cell Stem Cell. 2021 09 02; 28(9):1533-1548.e6. Mertens J, Herdy JR, Traxler L, Schafer ST, Schlachetzki JCM, Böhnke L, Reid DA, Lee H, Zangwill D, Fernandes DP, Agarwal RK, Lucciola R, Zhou-Yang L, Karbacher L, Edenhofer F, Stern S, Horvath S, Paquola ACM, Glass CK, Yuan SH, Ku M, Szücs A, Goldstein LSB, Galasko D, Gage FH. PMID: 33910058; PMCID: PMC8423435.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    76. Elevated plasma neurofilament light predicts a faster rate of cognitive decline over 5 years in participants with objectively-defined subtle cognitive decline and MCI. Alzheimers Dement. 2021 10; 17(10):1756-1762. Bangen KJ, Thomas KR, Weigand AJ, Edmonds EC, Clark AL, Solders S, Delano-Wood L, Galasko DR, Bondi MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 33860596; PMCID: PMC8517034.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    77. Preclinical validation of a potent γ-secretase modulator for Alzheimer's disease prevention. J Exp Med. 2021 04 05; 218(4). Rynearson KD, Ponnusamy M, Prikhodko O, Xie Y, Zhang C, Nguyen P, Hug B, Sawa M, Becker A, Spencer B, Florio J, Mante M, Salehi B, Arias C, Galasko D, Head BP, Johnson G, Lin JH, Duddy SK, Rissman RA, Mobley WC, Thinakaran G, Tanzi RE, Wagner SL. PMID: 33651103; PMCID: PMC7931646.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    78. Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia. Cortex. 2021 06; 139:99-115. Barker MS, Manoochehri M, Rizer SJ, Appleby BS, Brushaber D, Dev SI, Devick KL, Dickerson BC, Fields JA, Foroud TM, Forsberg LK, Galasko DR, Ghoshal N, Graff-Radford NR, Grossman M, Heuer HW, Hsiung GY, Kornak J, Litvan I, Mackenzie IR, Mendez MF, Pascual B, Rankin KP, Rascovsky K, Staffaroni AM, Tartaglia MC, Weintraub S, Wong B, Boeve BF, Boxer AL, Rosen HJ, Goldman J, Huey ED, Cosentino S, ALLFTD consortium. PMID: 33857770; PMCID: PMC8119343.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    79. Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson's disease progression. Nat Aging. 2021 03; 1(3):309-322. Kern F, Fehlmann T, Violich I, Alsop E, Hutchins E, Kahraman M, Grammes NL, Guimarães P, Backes C, Poston KL, Casey B, Balling R, Geffers L, Krüger R, Galasko D, Mollenhauer B, Meese E, Wyss-Coray T, Craig DW, Van Keuren-Jensen K, Keller A. PMID: 37118411.
      View in: PubMed   Mentions: 13  Translation:HumansCells
    80. Age-at-Onset and APOE-Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer Disease. Neurology. 2021 05 04; 96(18):e2272-e2283. Smirnov DS, Galasko D, Hiniker A, Edland SD, Salmon DP. PMID: 33722993; PMCID: PMC8166435.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    81. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet. 2021 03; 53(3):294-303. Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E, Walton RL, Ahmed S, Viollet C, Ding J, Makarious MB, Diez-Fairen M, Portley MK, Shah Z, Abramzon Y, Hernandez DG, Blauwendraat C, Stone DJ, Eicher J, Parkkinen L, Ansorge O, Clark L, Honig LS, Marder K, Lemstra A, St George-Hyslop P, Londos E, Morgan K, Lashley T, Warner TT, Jaunmuktane Z, Galasko D, Santana I, Tienari PJ, Myllykangas L, Oinas M, Cairns NJ, Morris JC, Halliday GM, Van Deerlin VM, Trojanowski JQ, Grassano M, Calvo A, Mora G, Canosa A, Floris G, Bohannan RC, Brett F, Gan-Or Z, Geiger JT, Moore A, May P, Krüger R, Goldstein DS, Lopez G, Tayebi N, Sidransky E, American Genome Center, Norcliffe-Kaufmann L, Palma JA, Kaufmann H, Shakkottai VG, Perkins M, Newell KL, Gasser T, Schulte C, Landi F, Salvi E, Cusi D, Masliah E, Kim RC, Caraway CA, Monuki ES, Brunetti M, Dawson TM, Rosenthal LS, Albert MS, Pletnikova O, Troncoso JC, Flanagan ME, Mao Q, Bigio EH, Rodríguez-Rodríguez E, Infante J, Lage C, González-Aramburu I, Sanchez-Juan P, Ghetti B, Keith J, Black SE, Masellis M, Rogaeva E, Duyckaerts C, Brice A, Lesage S, Xiromerisiou G, Barrett MJ, Tilley BS, Gentleman S, Logroscino G, Serrano GE, Beach TG, McKeith IG, Thomas AJ, Attems J, Morris CM, Palmer L, Love S, Troakes C, Al-Sarraj S, Hodges AK, Aarsland D, Klein G, Kaiser SM, Woltjer R, Pastor P, Bekris LM, Leverenz JB, Besser LM, Kuzma A, Renton AE, Goate A, Bennett DA, Scherzer CR, Morris HR, Ferrari R, Albani D, Pickering-Brown S, Faber K, Kukull WA, Morenas-Rodriguez E, Lleó A, Fortea J, Alcolea D, Clarimon J, Nalls MA, Ferrucci L, Resnick SM, Tanaka T, Foroud TM, Graff-Radford NR, Wszolek ZK, Ferman T, Boeve BF, Hardy JA, Topol EJ, Torkamani A, Singleton AB, Ryten M, Dickson DW, Chiò A, Ross OA, Gibbs JR, Dalgard CL, Traynor BJ, Scholz SW. PMID: 33589841; PMCID: PMC7946812.
      View in: PubMed   Mentions: 116     Fields:    Translation:Humans
    82. The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α-Synuclein in PDGBA. Mov Disord. 2021 05; 36(5):1216-1228. Lerche S, Schulte C, Wurster I, Machetanz G, Roeben B, Zimmermann M, Deuschle C, Hauser AK, Böhringer J, Krägeloh-Mann I, Waniek K, Lachmann I, Petterson XT, Chiang R, Park H, Wang B, Liepelt-Scarfone I, Maetzler W, Galasko D, Scherzer CR, Gasser T, Mielke MM, Hutten SJ, Mollenhauer B, Sardi SP, Berg D, Brockmann K. PMID: 33547828.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    83. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology. J Alzheimers Dis. 2021; 80(3):1243-1256. Ryman SG, Yutsis M, Tian L, Henderson VW, Montine TJ, Salmon DP, Galasko D, Poston KL. PMID: 33646154; PMCID: PMC8150665.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    84. A rapid α-synuclein seed assay of Parkinson's disease CSF panel shows high diagnostic accuracy. Ann Clin Transl Neurol. 2021 02; 8(2):374-384. Orrù CD, Ma TC, Hughson AG, Groveman BR, Srivastava A, Galasko D, Angers R, Downey P, Crawford K, Hutten SJ, Kang UJ, Caughey B. PMID: 33373501; PMCID: PMC7886040.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    85. Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder. Ann Clin Transl Neurol. 2021 01; 8(1):201-212. Chahine LM, Brumm MC, Caspell-Garcia C, Oertel W, Mollenhauer B, Amara A, Fernandez-Arcos A, Tolosa E, Simonet C, Hogl B, Videnovic A, Hutten SJ, Tanner C, Weintraub D, Burghardt E, Coffey C, Cho HR, Kieburtz K, Poston KL, Merchant K, Galasko D, Foroud T, Siderowf A, Marek K, Simuni T, Iranzo A. PMID: 33321002; PMCID: PMC7818144.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    86. Dedifferentiation and neuronal repression define familial Alzheimer's disease. Sci Adv. 2020 11; 6(46). Caldwell AB, Liu Q, Schroth GP, Galasko DR, Yuan SH, Wagner SL, Subramaniam S. PMID: 33188013; PMCID: PMC7673760.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    87. Correction to: Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC. Acta Neuropathol Commun. 2020 Nov 05; 8(1):180. Groveman BR, Orrù CD, Hughson AG, Raymond LD, Zanusso G, Ghetti B, Campbell KJ, Safar J, Galasko D, Caughey B. PMID: 33153488; PMCID: PMC7643273.
      View in: PubMed   Mentions: 1     Fields:    
    88. Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study. Alzheimers Dement (Amst). 2020; 12(1):e12118. Marshall GA, Sikkes SAM, Amariglio RE, Gatchel JR, Rentz DM, Johnson KA, Langford O, Sun CK, Donohue MC, Raman R, Aisen PS, Sperling RA, Galasko DR, Full listing of A4 Study team and site personnel available at A4STUDY.org. PMID: 33163609; PMCID: PMC7596668.
      View in: PubMed   Mentions: 10  
    89. Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials. Alzheimers Res Ther. 2020 10 29; 12(1):137. Goldman JG, Forsberg LK, Boeve BF, Armstrong MJ, Irwin DJ, Ferman TJ, Galasko D, Galvin JE, Kaufer D, Leverenz J, Lippa CF, Marder K, Abler V, Biglan K, Irizarry M, Keller B, Munsie L, Nakagawa M, Taylor A, Graham T. PMID: 33121510; PMCID: PMC7597002.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    90. Association of anticholinergic medications and AD biomarkers with incidence of MCI among cognitively normal older adults. Neurology. 2020 10 20; 95(16):e2295-e2304. Weigand AJ, Bondi MW, Thomas KR, Campbell NL, Galasko DR, Salmon DP, Sewell D, Brewer JB, Feldman HH, Delano-Wood L, Alzheimer's Disease Neuroimaging Initiative. PMID: 32878992; PMCID: PMC7713781.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    91. Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression. Mov Disord. 2020 11; 35(11):1999-2008. Mollenhauer B, Dakna M, Kruse N, Galasko D, Foroud T, Zetterberg H, Schade S, Gera RG, Wang W, Gao F, Frasier M, Chahine LM, Coffey CS, Singleton AB, Simuni T, Weintraub D, Seibyl J, Toga AW, Tanner CM, Kieburtz K, Marek K, Siderowf A, Cedarbaum JM, Hutten SJ, Trenkwalder C, Graham D. PMID: 32798333; PMCID: PMC8017468.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    92. Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease. Ann Neurol. 2020 09; 88(3):574-587. Irwin DJ, Fedler J, Coffey CS, Caspell-Garcia C, Kang JH, Simuni T, Foroud T, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Weintraub D, Mollenhauer B, Galasko DR, Siderowf A, Marek K, Trojanowski JQ, Shaw LM, Parkinson's Progression Marker Initiative. PMID: 32542885; PMCID: PMC7497251.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    93. Community memory screening as a strategy for recruiting older adults into Alzheimer's disease research. Alzheimers Res Ther. 2020 06 30; 12(1):78. Peavy GM, Jenkins CW, Little EA, Gigliotti C, Calcetas A, Edland SD, Brewer JB, Galasko D, Salmon DP. PMID: 32605603; PMCID: PMC7325657.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    94. Failure to stop autocorrect errors in reading aloud increases in aging especially with a positive biomarker for Alzheimer's disease. Psychol Aging. 2020 Nov; 35(7):1016-1025. Gollan TH, Smirnov DS, Salmon DP, Galasko D. PMID: 32584071; PMCID: PMC8357184.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    95. Sex differences in Alzheimer's-related Tau biomarkers and a mediating effect of testosterone. Biol Sex Differ. 2020 06 19; 11(1):33. Sundermann EE, Panizzon MS, Chen X, Andrews M, Galasko D, Banks SJ, Alzheimer’s Disease Neuroimaging Initiative. PMID: 32560743; PMCID: PMC7304096.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    96. A decade of Alzheimer's Research & Therapy: reflections on the past, present, and future. Alzheimers Res Ther. 2020 05 30; 12(1):67. Galasko D, Scheltens P. PMID: 32473646; PMCID: PMC7260791.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    97. Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies. Neurology. 2020 05 19; 94(20):e2076-e2087. Smirnov DS, Galasko D, Edland SD, Filoteo JV, Hansen LA, Salmon DP. PMID: 32332125; PMCID: PMC7526670.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    98. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020 04 28; 94(17):743-755. McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, Kantarci K, Muscio C, O'Brien JT, Postuma RB, Aarsland D, Ballard C, Bonanni L, Donaghy P, Emre M, Galvin JE, Galasko D, Goldman JG, Gomperts SN, Honig LS, Ikeda M, Leverenz JB, Lewis SJG, Marder KS, Masellis M, Salmon DP, Taylor JP, Tsuang DW, Walker Z, Tiraboschi P, prodromal DLB Diagnostic Study Group. PMID: 32241955; PMCID: PMC7274845.
      View in: PubMed   Mentions: 166     Fields:    Translation:Humans
    99. Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study. Mov Disord. 2020 05; 35(5):833-844. Simuni T, Brumm MC, Uribe L, Caspell-Garcia C, Coffey CS, Siderowf A, Alcalay RN, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Nudelman K, Tosun-Turgut D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Bressman S, Marek K, Parkinson's Progression Markers Initiative Investigators. PMID: 32073681; PMCID: PMC7231646.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    100. Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies. Acta Neuropathol Commun. 2020 01 29; 8(1):5. Orme T, Hernandez D, Ross OA, Kun-Rodrigues C, Darwent L, Shepherd CE, Parkkinen L, Ansorge O, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Trojanowski JQ, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday G, Stone DJ, Dickson DW, Hardy J, Singleton A, Guerreiro R, Bras J. PMID: 31996268; PMCID: PMC6990558.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    101. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020 01; 577(7790):399-404. Gate D, Saligrama N, Leventhal O, Yang AC, Unger MS, Middeldorp J, Chen K, Lehallier B, Channappa D, De Los Santos MB, McBride A, Pluvinage J, Elahi F, Tam GK, Kim Y, Greicius M, Wagner AD, Aigner L, Galasko DR, Davis MM, Wyss-Coray T. PMID: 31915375; PMCID: PMC7445078.
      View in: PubMed   Mentions: 325     Fields:    Translation:HumansCells
    102. Correction to: 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration. Acta Neuropathol. 2020 Jan; 139(1):79-81. Saijo E, Metrick MA, Koga S, Parchi P, Litvan I, Spina S, Boxer A, Rojas JC, Galasko D, Kraus A, Rossi M, Newell K, Zanusso G, Grinberg LT, Seeley WW, Ghetti B, Dickson DW, Caughey B. PMID: 31748840; PMCID: PMC7193369.
      View in: PubMed   Mentions: 2     Fields:    
    103. Anterior Cingulate Structure and Perfusion is Associated with Cerebrospinal Fluid Tau among Cognitively Normal Older Adult APOEɛ4 Carriers. J Alzheimers Dis. 2020; 73(1):87-101. Hays CC, Zlatar ZZ, Meloy MJ, Osuna J, Liu TT, Galasko DR, Wierenga CE. PMID: 31743999; PMCID: PMC7310575.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    104. Associations Between Microstructure, Amyloid, and Cognition in Amnestic Mild Cognitive Impairment and Dementia. J Alzheimers Dis. 2020; 73(1):347-357. Reas ET, Hagler DJ, Kuperman JM, Wierenga CE, Galasko D, White NS, Dale AM, Banks SJ, McEvoy LK, Brewer JB. PMID: 31796676; PMCID: PMC7266036.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    105. Performance of Validated MicroRNA Biomarkers for Alzheimer's Disease in Mild Cognitive Impairment. J Alzheimers Dis. 2020; 78(1):245-263. Sandau US, Wiedrick JT, Smith SJ, McFarland TJ, Lusardi TA, Lind B, Harrington CA, Lapidus JA, Galasko DR, Quinn JF, Saugstad JA. PMID: 32955460; PMCID: PMC9262405.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    106. Maximizing Safety in the Conduct of Alzheimer's Disease Fluid Biomarker Research in the Era of COVID-19. J Alzheimers Dis. 2020; 76(1):27-31. Schindler SE, Jicha GA, Nelson PT, Keene CD, Blennow K, Molinuevo JL, Masters CL, Hansson O, Teunissen CE, Galasko D, Shaw LM, Levey AI, Silverberg N. PMID: 32568212; PMCID: PMC7995336.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    107. Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease. Alzheimers Dement (N Y). 2019; 5:871-882. Galasko D, Xiao M, Xu D, Smirnov D, Salmon DP, Dewit N, Vanbrabant J, Jacobs D, Vanderstichele H, Vanmechelen E, Alzheimer's Disease Neuroimaging Initiative (ADNI), Worley P. PMID: 31853477; PMCID: PMC6911971.
      View in: PubMed   Mentions: 50  
    108. miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer's Patients. Front Neurosci. 2019; 13:1208. Cha DJ, Mengel D, Mustapic M, Liu W, Selkoe DJ, Kapogiannis D, Galasko D, Rissman RA, Bennett DA, Walsh DM. PMID: 31849573; PMCID: PMC6902042.
      View in: PubMed   Mentions: 84  
    109. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study. Lancet Neurol. 2020 01; 19(1):71-80. Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Tosun D, Poston K, Weintraub D, Mollenhauer B, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten SJ, Bressman S, Marek K, PPMI Investigators. PMID: 31678032; PMCID: PMC6956652.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    110. 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration. Acta Neuropathol. 2020 01; 139(1):63-77. Saijo E, Metrick MA, Koga S, Parchi P, Litvan I, Spina S, Boxer A, Rojas JC, Galasko D, Kraus A, Rossi M, Newell K, Zanusso G, Grinberg LT, Seeley WW, Ghetti B, Dickson DW, Caughey B. PMID: 31616982; PMCID: PMC7192393.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    111. MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2019 10; 15(10):1322-1332. Thomas KR, Edmonds EC, Eppig JS, Wong CG, Weigand AJ, Bangen KJ, Jak AJ, Delano-Wood L, Galasko DR, Salmon DP, Edland SD, Bondi MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 31495605; PMCID: PMC6801026.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    112. Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet. 2019 Sep; 51(9):1423-1424. Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, Badarinarayan N, Jakobsdottir J, Hamilton-Nelson KL, Moreno-Grau S, Olaso R, Raybould R, Chen Y, Kuzma AB, Hiltunen M, Morgan T, Ahmad S, Vardarajan BN, Epelbaum J, Hoffmann P, Boada M, Beecham GW, Garnier JG, Harold D, Fitzpatrick AL, Valladares O, Moutet ML, Gerrish A, Smith AV, Qu L, Bacq D, Denning N, Jian X, Zhao Y, Del Zompo M, Fox NC, Choi SH, Mateo I, Hughes JT, Adams HH, Malamon J, Sanchez-Garcia F, Patel Y, Brody JA, Dombroski BA, Naranjo MCD, Daniilidou M, Eiriksdottir G, Mukherjee S, Wallon D, Uphill J, Aspelund T, Cantwell LB, Garzia F, Galimberti D, Hofer E, Butkiewicz M, Fin B, Scarpini E, Sarnowski C, Bush WS, Meslage S, Kornhuber J, White CC, Song Y, Barber RC, Engelborghs S, Sordon S, Voijnovic D, Adams PM, Vandenberghe R, Mayhaus M, Cupples LA, Albert MS, De Deyn PP, Gu W, Himali JJ, Beekly D, Squassina A, Hartmann AM, Orellana A, Blacker D, Rodriguez-Rodriguez E, Lovestone S, Garcia ME, Doody RS, Munoz-Fernadez C, Sussams R, Lin H, Fairchild TJ, Benito YA, Holmes C, Karamujic-Comic H, Frosch MP, Thonberg H, Maier W, Roshchupkin G, Ghetti B, Giedraitis V, Kawalia A, Li S, Huebinger RM, Kilander L, Moebus S, Hernández I, Kamboh MI, Brundin R, Turton J, Yang Q, Katz MJ, Concari L, Lord J, Beiser AS, Keene CD, Helisalmi S, Kloszewska I, Kukull WA, Koivisto AM, Lynch A, Tarraga L, Larson EB, Haapasalo A, Lawlor B, Mosley TH, Lipton RB, Solfrizzi V, Gill M, Longstreth WT, Montine TJ, Frisardi V, Diez-Fairen M, Rivadeneira F, Petersen RC, Deramecourt V, Alvarez I, Salani F, Ciaramella A, Boerwinkle E, Reiman EM, Fievet N, Rotter JI, Reisch JS, Hanon O, Cupidi C, Uitterlinden AGA, Royall DR, Dufouil C, Maletta RG, de Rojas I, Sano M, Brice A, Cecchetti R, George-Hyslop PS, Ritchie K, Tsolaki M, Tsuang DW, Dubois B, Craig D, Wu CK, Soininen H, Avramidou D, Albin RL, Fratiglioni L, Germanou A, Apostolova LG, Keller L, Koutroumani M, Arnold SE, Panza F, Gkatzima O, Asthana S, Hannequin D, Whitehead P, Atwood CS, Caffarra P, Hampel H, Quintela I, Carracedo Á, Lannfelt L, Rubinsztein DC, Barnes LL, Pasquier F, Frölich L, Barral S, McGuinness B, Beach TG, Johnston JA, Becker JT, Passmore P, Bigio EH, Schott JM, Bird TD, Warren JD, Boeve BF, Lupton MK, Bowen JD, Proitsi P, Boxer A, Powell JF, Burke JR, Kauwe JSK, Burns JM, Mancuso M, Buxbaum JD, Bonuccelli U, Cairns NJ, McQuillin A, Cao C, Livingston G, Carlson CS, Bass NJ, Carlsson CM, Hardy J, Carney RM, Bras J, Carrasquillo MM, Guerreiro R, Allen M, Chui HC, Fisher E, Masullo C, Crocco EA, DeCarli C, Bisceglio G, Dick M, Ma L, Duara R, Graff-Radford NR, Evans DA, Hodges A, Faber KM, Scherer M, Fallon KB, Riemenschneider M, Fardo DW, Heun R, Farlow MR, Kölsch H, Ferris S, Leber M, Foroud TM, Heuser I, Galasko DR, Giegling I, Gearing M, Hüll M, Geschwind DH, Gilbert JR, Morris J, Green RC, Mayo K, Growdon JH, Feulner T, Hamilton RL, Harrell LE, Drichel D, Honig LS, Cushion TD, Huentelman MJ, Hollingworth P, Hulette CM, Hyman BT, Marshall R, Jarvik GP, Meggy A, Abner E, Menzies GE, Jin LW, Leonenko G, Real LM, Jun GR, Baldwin CT, Grozeva D, Karydas A, Russo G, Kaye JA, Kim R, Jessen F, Kowall NW, Vellas B, Kramer JH, Vardy E, LaFerla FM, Jöckel KH, Lah JJ, Dichgans M, Leverenz JB, Mann D, Levey AI, Pickering-Brown S, Lieberman AP, Klopp N, Lunetta KL, Wichmann HE, Lyketsos CG, Morgan K, Marson DC, Brown K, Martiniuk F, Medway C, Mash DC, Nöthen MM, et al. PMID: 31417202; PMCID: PMC7265117.
      View in: PubMed   Mentions: 28     Fields:    
    113. Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease. Mov Disord. 2019 09; 34(9):1354-1364. Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Singleton A, Shaw LM, Trojanowski JQ, Frasier M, Simuni T, Iranzo A, Oertel W, Siderowf A, Weintraub D, Seibyl J, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Marek K, Galasko D, PPMI study. PMID: 31361367; PMCID: PMC7098385.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    114. Distinct structural correlates of the dominant and nondominant languages in bilinguals with Alzheimer's disease (AD). Neuropsychologia. 2019 09; 132:107131. Smirnov DS, Stasenko A, Salmon DP, Galasko D, Brewer JB, Gollan TH. PMID: 31271821; PMCID: PMC6702045.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    115. Heritability and genetic variance of dementia with Lewy bodies. Neurobiol Dis. 2019 07; 127:492-501. Guerreiro R, Escott-Price V, Hernandez DG, Kun-Rodrigues C, Ross OA, Orme T, Neto JL, Carmona S, Dehghani N, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, International Parkinson's Disease Genomics Consortium, Stone DJ, Bras J. PMID: 30953760; PMCID: PMC6588425.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    116. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers. Brain. 2019 04 01; 142(4):1063-1076. Gordon BA, Blazey TM, Christensen J, Dincer A, Flores S, Keefe S, Chen C, Su Y, McDade EM, Wang G, Li Y, Hassenstab J, Aschenbrenner A, Hornbeck R, Jack CR, Ances BM, Berman SB, Brosch JR, Galasko D, Gauthier S, Lah JJ, Masellis M, van Dyck CH, Mintun MA, Klein G, Ristic S, Cairns NJ, Marcus DS, Xiong C, Holtzman DM, Raichle ME, Morris JC, Bateman RJ, Benzinger TLS. PMID: 30753379; PMCID: PMC6439328.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCells
    117. Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings. Alzheimers Res Ther. 2019 03 13; 11(1):23. Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, Domoto-Reilly K, Duda J, Gomperts S, Graff-Radford N, Holden S, Honig L, Huddleston D, Lippa C, Litvan I, Manning C, Marder K, Moussa C, Onyike C, Pagan F, Pantelyat A, Pelak V, Poston K, Quinn J, Richard I, Rosenthal LS, Sabbagh M, Scharre D, Sha S, Shill H, Torres-Yaghi Y, Christie T, Graham T, Richards I, Koehler M, Boeve B. PMID: 30867052; PMCID: PMC6417280.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    118. Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet. 2019 03; 51(3):414-430. Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A, Bellenguez C, Frizatti A, Chouraki V, Martin ER, Sleegers K, Badarinarayan N, Jakobsdottir J, Hamilton-Nelson KL, Moreno-Grau S, Olaso R, Raybould R, Chen Y, Kuzma AB, Hiltunen M, Morgan T, Ahmad S, Vardarajan BN, Epelbaum J, Hoffmann P, Boada M, Beecham GW, Garnier JG, Harold D, Fitzpatrick AL, Valladares O, Moutet ML, Gerrish A, Smith AV, Qu L, Bacq D, Denning N, Jian X, Zhao Y, Del Zompo M, Fox NC, Choi SH, Mateo I, Hughes JT, Adams HH, Malamon J, Sanchez-Garcia F, Patel Y, Brody JA, Dombroski BA, Naranjo MCD, Daniilidou M, Eiriksdottir G, Mukherjee S, Wallon D, Uphill J, Aspelund T, Cantwell LB, Garzia F, Galimberti D, Hofer E, Butkiewicz M, Fin B, Scarpini E, Sarnowski C, Bush WS, Meslage S, Kornhuber J, White CC, Song Y, Barber RC, Engelborghs S, Sordon S, Voijnovic D, Adams PM, Vandenberghe R, Mayhaus M, Cupples LA, Albert MS, De Deyn PP, Gu W, Himali JJ, Beekly D, Squassina A, Hartmann AM, Orellana A, Blacker D, Rodriguez-Rodriguez E, Lovestone S, Garcia ME, Doody RS, Munoz-Fernadez C, Sussams R, Lin H, Fairchild TJ, Benito YA, Holmes C, Karamujic-Comic H, Frosch MP, Thonberg H, Maier W, Roshchupkin G, Ghetti B, Giedraitis V, Kawalia A, Li S, Huebinger RM, Kilander L, Moebus S, Hernández I, Kamboh MI, Brundin R, Turton J, Yang Q, Katz MJ, Concari L, Lord J, Beiser AS, Keene CD, Helisalmi S, Kloszewska I, Kukull WA, Koivisto AM, Lynch A, Tarraga L, Larson EB, Haapasalo A, Lawlor B, Mosley TH, Lipton RB, Solfrizzi V, Gill M, Longstreth WT, Montine TJ, Frisardi V, Diez-Fairen M, Rivadeneira F, Petersen RC, Deramecourt V, Alvarez I, Salani F, Ciaramella A, Boerwinkle E, Reiman EM, Fievet N, Rotter JI, Reisch JS, Hanon O, Cupidi C, Andre Uitterlinden AG, Royall DR, Dufouil C, Maletta RG, de Rojas I, Sano M, Brice A, Cecchetti R, George-Hyslop PS, Ritchie K, Tsolaki M, Tsuang DW, Dubois B, Craig D, Wu CK, Soininen H, Avramidou D, Albin RL, Fratiglioni L, Germanou A, Apostolova LG, Keller L, Koutroumani M, Arnold SE, Panza F, Gkatzima O, Asthana S, Hannequin D, Whitehead P, Atwood CS, Caffarra P, Hampel H, Quintela I, Carracedo Á, Lannfelt L, Rubinsztein DC, Barnes LL, Pasquier F, Frölich L, Barral S, McGuinness B, Beach TG, Johnston JA, Becker JT, Passmore P, Bigio EH, Schott JM, Bird TD, Warren JD, Boeve BF, Lupton MK, Bowen JD, Proitsi P, Boxer A, Powell JF, Burke JR, Kauwe JSK, Burns JM, Mancuso M, Buxbaum JD, Bonuccelli U, Cairns NJ, McQuillin A, Cao C, Livingston G, Carlson CS, Bass NJ, Carlsson CM, Hardy J, Carney RM, Bras J, Carrasquillo MM, Guerreiro R, Allen M, Chui HC, Fisher E, Masullo C, Crocco EA, DeCarli C, Bisceglio G, Dick M, Ma L, Duara R, Graff-Radford NR, Evans DA, Hodges A, Faber KM, Scherer M, Fallon KB, Riemenschneider M, Fardo DW, Heun R, Farlow MR, Kölsch H, Ferris S, Leber M, Foroud TM, Heuser I, Galasko DR, Giegling I, Gearing M, Hüll M, Geschwind DH, Gilbert JR, Morris J, Green RC, Mayo K, Growdon JH, Feulner T, Hamilton RL, Harrell LE, Drichel D, Honig LS, Cushion TD, Huentelman MJ, Hollingworth P, Hulette CM, Hyman BT, Marshall R, Jarvik GP, Meggy A, Abner E, Menzies GE, Jin LW, Leonenko G, Real LM, Jun GR, Baldwin CT, Grozeva D, Karydas A, Russo G, Kaye JA, Kim R, Jessen F, Kowall NW, Vellas B, Kramer JH, Vardy E, LaFerla FM, Jöckel KH, Lah JJ, Dichgans M, Leverenz JB, Mann D, Levey AI, Pickering-Brown S, Lieberman AP, Klopp N, Lunetta KL, Wichmann HE, Lyketsos CG, Morgan K, Marson DC, Brown K, Martiniuk F, Medway C, Mash DC, Nöthen MM, et al. PMID: 30820047; PMCID: PMC6463297.
      View in: PubMed   Mentions: 1105     Fields:    Translation:Humans
    119. Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies. Alzheimers Dement (Amst). 2019 Dec; 11:180-190. Su Y, Flores S, Wang G, Hornbeck RC, Speidel B, Joseph-Mathurin N, Vlassenko AG, Gordon BA, Koeppe RA, Klunk WE, Jack CR, Farlow MR, Salloway S, Snider BJ, Berman SB, Roberson ED, Brosch J, Jimenez-Velazques I, van Dyck CH, Galasko D, Yuan SH, Jayadev S, Honig LS, Gauthier S, Hsiung GR, Masellis M, Brooks WS, Fulham M, Clarnette R, Masters CL, Wallon D, Hannequin D, Dubois B, Pariente J, Sanchez-Valle R, Mummery C, Ringman JM, Bottlaender M, Klein G, Milosavljevic-Ristic S, McDade E, Xiong C, Morris JC, Bateman RJ, Benzinger TLS. PMID: 30847382; PMCID: PMC6389727.
      View in: PubMed   Mentions: 58  
    120. Early versus late MCI: Improved MCI staging using a neuropsychological approach. Alzheimers Dement. 2019 05; 15(5):699-708. Edmonds EC, McDonald CR, Marshall A, Thomas KR, Eppig J, Weigand AJ, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 30737119; PMCID: PMC6511470.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    121. Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI). Parkinsonism Relat Disord. 2019 05; 62:201-209. Prakash N, Caspell-Garcia C, Coffey C, Siderowf A, Tanner CM, Kieburtz K, Mollenhauer B, Galasko D, Merchant K, Foroud T, Chahine LM, Weintraub D, Casaceli C, Dorsey R, Wilson R, Herzog M, Daegele N, Arnedo V, Frasier M, Sherer T, Marek K, Frank S, Jennings D, Simuni T, Parkinson's Progression Markers InitiativeSteering Committee, Study Cores, Site Investigators, Coordinators, Industry and Scientific Advisory Board. PMID: 30738748; PMCID: PMC8978879.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    122. Alzheimer's disease and the processing of uncertainty during choice task performance: Executive dysfunction within the Hick-Hyman law. J Clin Exp Neuropsychol. 2019 05; 41(4):380-389. Korthauer LE, Salmon DP, Festa EK, Galasko D, Heindel WC. PMID: 30632903; PMCID: PMC6428614.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    123. Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement. 2019 04; 15(4):561-569. Thomas KR, Eppig JS, Weigand AJ, Edmonds EC, Wong CG, Jak AJ, Delano-Wood L, Galasko DR, Salmon DP, Edland SD, Bondi MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 30610833; PMCID: PMC6461519.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    124. Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid. J Alzheimers Dis. 2019; 67(3):875-891. Wiedrick JT, Phillips JI, Lusardi TA, McFarland TJ, Lind B, Sandau US, Harrington CA, Lapidus JA, Galasko DR, Quinn JF, Saugstad JA. PMID: 30689565; PMCID: PMC6687305.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    125. Neuropsychological Deficit Profiles, Vascular Risk Factors, and Neuropathological Findings in Hispanic Older Adults with Autopsy-Confirmed Alzheimer's Disease. J Alzheimers Dis. 2019; 67(1):291-302. Weissberger GH, Gollan TH, Bondi MW, Nation DA, Hansen LA, Galasko D, Salmon DP. PMID: 30636736; PMCID: PMC6925532.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    126. Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change Measures. J Parkinsons Dis. 2019; 9(4):665-679. Chahine LM, Siderowf A, Barnes J, Seedorff N, Caspell-Garcia C, Simuni T, Coffey CS, Galasko D, Mollenhauer B, Arnedo V, Daegele N, Frasier M, Tanner C, Kieburtz K, Marek K, The Parkinson’s Progression Markers Initiative. PMID: 31450510; PMCID: PMC6839498.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    127. Alzheimer's disease: The right drug, the right time. Science. 2018 12 14; 362(6420):1250-1251. Golde TE, DeKosky ST, Galasko D. PMID: 30545877.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    128. Trajectories of cognitive decline differ in hippocampal sclerosis and Alzheimer's disease. Neurobiol Aging. 2019 03; 75:169-177. Smirnov DS, Galasko D, Hansen LA, Edland SD, Brewer JB, Salmon DP. PMID: 30579145; PMCID: PMC6492933.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    129. Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease. Alzheimers Dement. 2019 03; 15(3):487-496. Chen Z, Mengel D, Keshavan A, Rissman RA, Billinton A, Perkinton M, Percival-Alwyn J, Schultz A, Properzi M, Johnson K, Selkoe DJ, Sperling RA, Patel P, Zetterberg H, Galasko D, Schott JM, Walsh DM. PMID: 30419228; PMCID: PMC6476313.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    130. The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort. Ann Clin Transl Neurol. 2018 Dec; 5(12):1460-1477. Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun-Turgut D, Poston K, Arnedo V, Frasier M, Sherer T, Parkinson's Progression Markers Initiative. PMID: 30564614; PMCID: PMC6292383.
      View in: PubMed   Mentions: 157     Fields:    
    131. A comprehensive screening of copy number variability in dementia with Lewy bodies. Neurobiol Aging. 2019 03; 75:223.e1-223.e10. Kun-Rodrigues C, Orme T, Carmona S, Hernandez DG, Ross OA, Eicher JD, Shepherd C, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Dawson T, Rosenthal L, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Guerreiro R, Bras J. PMID: 30448004; PMCID: PMC6541211.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    132. Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease. Alzheimers Dement. 2018 11; 14(11):1505-1521. Shaw LM, Arias J, Blennow K, Galasko D, Molinuevo JL, Salloway S, Schindler S, Carrillo MC, Hendrix JA, Ross A, Illes J, Ramus C, Fifer S. PMID: 30316776; PMCID: PMC10013957.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    133. Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord. 2018 Oct-Dec; 32(4):351-358. Besser L, Kukull W, Knopman DS, Chui H, Galasko D, Weintraub S, Jicha G, Carlsson C, Burns J, Quinn J, Sweet RA, Rascovsky K, Teylan M, Beekly D, Thomas G, Bollenbeck M, Monsell S, Mock C, Zhou XH, Thomas N, Robichaud E, Dean M, Hubbard J, Jacka M, Schwabe-Fry K, Wu J, Phelps C, Morris JC, Neuropsychology Work Group, Directors, and Clinical Core leaders of the National Institute on Aging-. PMID: 30376508; PMCID: PMC6249084.
      View in: PubMed   Mentions: 182     Fields:    Translation:Humans
    134. Microstructural brain changes track cognitive decline in mild cognitive impairment. Neuroimage Clin. 2018; 20:883-891. Reas ET, Hagler DJ, White NS, Kuperman JM, Bartsch H, Wierenga CE, Galasko D, Brewer JB, Dale AM, McEvoy LK. PMID: 30290303; PMCID: PMC6171091.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    135. Subjective Cognitive Decline Correlates With Depression Symptoms and Not With Concurrent Objective Cognition in a Clinic-Based Sample of Older Adults. J Gerontol B Psychol Sci Soc Sci. 2018 09 20; 73(7):1198-1202. Zlatar ZZ, Muniz M, Galasko D, Salmon DP. PMID: 28329816; PMCID: PMC6146771.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    136. Increasing Inaccuracy of Self-Reported Subjective Cognitive Complaints Over 24 Months in Empirically Derived Subtypes of Mild Cognitive Impairment. J Int Neuropsychol Soc. 2018 09; 24(8):842-853. Edmonds EC, Weigand AJ, Thomas KR, Eppig J, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW. PMID: 30278855; PMCID: PMC6173206.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    137. α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies. Proc Natl Acad Sci U S A. 2018 07 24; 115(30):7813-7818. Prots I, Grosch J, Brazdis RM, Simmnacher K, Veber V, Havlicek S, Hannappel C, Krach F, Krumbiegel M, Schütz O, Reis A, Wrasidlo W, Galasko DR, Groemer TW, Masliah E, Schlötzer-Schrehardt U, Xiang W, Winkler J, Winner B. PMID: 29991596; PMCID: PMC6065020.
      View in: PubMed   Mentions: 102     Fields:    Translation:HumansCells
    138. Primary brain calcification: an international study reporting novel variants and associated phenotypes. Eur J Hum Genet. 2018 10; 26(10):1462-1477. Ramos EM, Carecchio M, Lemos R, Ferreira J, Legati A, Sears RL, Hsu SC, Panteghini C, Magistrelli L, Salsano E, Esposito S, Taroni F, Richard AC, Tranchant C, Anheim M, Ayrignac X, Goizet C, Vidailhet M, Maltete D, Wallon D, Frebourg T, Pimentel L, Geschwind DH, Vanakker O, Galasko D, Fogel BL, Innes AM, Ross A, Dobyns WB, Alcantara D, O'Driscoll M, Hannequin D, Campion D, French PFBC study group, Oliveira JR, Garavaglia B, Coppola G, Nicolas G. PMID: 29955172; PMCID: PMC6138755.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    139. Preferential degradation of cognitive networks differentiates Alzheimer's disease from ageing. Brain. 2018 05 01; 141(5):1486-1500. Chhatwal JP, Schultz AP, Johnson KA, Hedden T, Jaimes S, Benzinger TLS, Jack C, Ances BM, Ringman JM, Marcus DS, Ghetti B, Farlow MR, Danek A, Levin J, Yakushev I, Laske C, Koeppe RA, Galasko DR, Xiong C, Masters CL, Schofield PR, Kinnunen KM, Salloway S, Martins RN, McDade E, Cairns NJ, Buckles VD, Morris JC, Bateman R, Sperling RA, Dominantly Inherited Alzheimer Network. PMID: 29522171; PMCID: PMC5917745.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    140. Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort. Mov Disord. 2018 05; 33(5):771-782. Simuni T, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun D, Poston K, Arnedo V, Frasier M, Sherer T, Chowdhury S, Marek K, Parkinson's Progression Marker Initiative*. PMID: 29572948; PMCID: PMC6001458.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    141. APOE DNA methylation is altered in Lewy body dementia. Alzheimers Dement. 2018 07; 14(7):889-894. Tulloch J, Leong L, Chen S, Keene CD, Millard SP, Shutes-David A, Lopez OL, Kofler J, Kaye JA, Woltjer R, Nelson PT, Neltner JH, Jicha GA, Galasko D, Masliah E, Leverenz JB, Yu CE, Tsuang D. PMID: 29544979; PMCID: PMC6050144.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    142. Associations between CSF cortisol and CSF norepinephrine in cognitively normal controls and patients with amnestic MCI and AD dementia. Int J Geriatr Psychiatry. 2018 05; 33(5):763-768. Wang LY, Raskind MA, Wilkinson CW, Shofer JB, Sikkema C, Szot P, Quinn JF, Galasko DR, Peskind ER. PMID: 29446123; PMCID: PMC5882504.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    143. Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC. Acta Neuropathol Commun. 2018 02 09; 6(1):7. Groveman BR, Orrù CD, Hughson AG, Raymond LD, Zanusso G, Ghetti B, Campbell KJ, Safar J, Galasko D, Caughey B. PMID: 29422107; PMCID: PMC5806364.
      View in: PubMed   Mentions: 155     Fields:    Translation:Humans
    144. Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype. Autophagy. 2018; 14(1):98-119. Minakaki G, Menges S, Kittel A, Emmanouilidou E, Schaeffner I, Barkovits K, Bergmann A, Rockenstein E, Adame A, Marxreiter F, Mollenhauer B, Galasko D, Buzás EI, Schlötzer-Schrehardt U, Marcus K, Xiang W, Lie DC, Vekrellis K, Masliah E, Winkler J, Klucken J. PMID: 29198173; PMCID: PMC5846507.
      View in: PubMed   Mentions: 130     Fields:    Translation:HumansAnimalsCells
    145. Sex Influences the Accuracy of Subjective Memory Complaint Reporting in Older Adults. J Alzheimers Dis. 2018; 61(3):1163-1178. Sundermann EE, Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Rubin LH, Bondi MW, Alzheimer’s Disease Neuroimaging Initiative. PMID: 29332038.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    146. A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment. J Alzheimers Dis. 2018; 61(4):1541-1553. Wang H, Stewart T, Toledo JB, Ginghina C, Tang L, Atik A, Aro P, Shaw LM, Trojanowski JQ, Galasko DR, Edland S, Jensen PH, Shi M, Zhang J, Alzheimer’s Disease Neuroimaging Initiative. PMID: 29376878; PMCID: PMC5828159.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    147. Subjective Cognitive Decline, Objective Cognition, and Depression in Older Hispanics Screened for Memory Impairment. J Alzheimers Dis. 2018; 63(3):949-956. Zlatar ZZ, Muniz MC, Espinoza SG, Gratianne R, Gollan TH, Galasko D, Salmon DP. PMID: 29689718; PMCID: PMC5988433.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    148. Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino Volunteers. J Alzheimers Dis. 2018; 66(4):1539-1548. Soria JA, Huisa BN, Edland SD, Litvan I, Peavy GM, Salmon DP, Hansen LA, Galasko DR, Brewer JB, González HM, Rissman RA. PMID: 30412501.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    149. Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol. 2018 01; 17(1):64-74. Guerreiro R, Ross OA, Kun-Rodrigues C, Hernandez DG, Orme T, Eicher JD, Shepherd CE, Parkkinen L, Darwent L, Heckman MG, Scholz SW, Troncoso JC, Pletnikova O, Ansorge O, Clarimon J, Lleo A, Morenas-Rodriguez E, Clark L, Honig LS, Marder K, Lemstra A, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Serrano GE, Beach TG, Lesage S, Galasko D, Masliah E, Santana I, Pastor P, Diez-Fairen M, Aguilar M, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Pickering-Brown S, Mann D, Halliday GM, Hardy J, Trojanowski JQ, Dickson DW, Singleton A, Stone DJ, Bras J. PMID: 29263008; PMCID: PMC5805394.
      View in: PubMed   Mentions: 111     Fields:    Translation:Humans
    150. Unmasking the benefits of donepezil via psychometrically precise identification of mild cognitive impairment: A secondary analysis of the ADCS vitamin E and donepezil in MCI study. Alzheimers Dement (N Y). 2018; 4:11-18. Edmonds EC, Ard MC, Edland SD, Galasko DR, Salmon DP, Bondi MW. PMID: 29296659; PMCID: PMC5738722.
      View in: PubMed   Mentions: 23  
    151. Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls. Neurology. 2017 11 07; 89(19):1959-1969. Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Shaw LM, Trojanowski JQ, Singleton A, Frasier M, Marek K, Galasko D, Parkinson's Progression Marker Initiative. PMID: 29030452; PMCID: PMC5679418.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    152. Potential implications of practice effects in Alzheimer's disease prevention trials. Alzheimers Dement (N Y). 2017 Nov; 3(4):531-535. Jacobs DM, Ard MC, Salmon DP, Galasko DR, Bondi MW, Edland SD. PMID: 29124111; PMCID: PMC5671629.
      View in: PubMed   Mentions: 12  
    153. Sensitivity of restriction spectrum imaging to memory and neuropathology in Alzheimer's disease. Alzheimers Res Ther. 2017 Aug 02; 9(1):55. Reas ET, Hagler DJ, White NS, Kuperman JM, Bartsch H, Cross K, Loi RQ, Balachandra AR, Meloy MJ, Wierenga CE, Galasko D, Brewer JB, Dale AM, McEvoy LK. PMID: 28764771; PMCID: PMC5539622.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    154. A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations. Mov Disord. 2017 Aug; 32(8):1117-1130. Mollenhauer B, Batrla R, El-Agnaf O, Galasko DR, Lashuel HA, Merchant KM, Shaw LM, Selkoe DJ, Umek R, Vanderstichele H, Zetterberg H, Zhang J, Caspell-Garcia C, Coffey C, Hutten SJ, Frasier M, Taylor P, Investigating Synuclein Consortium of the Michael J. Fox Foundation for Parkinson's Research. PMID: 28734051; PMCID: PMC5638072.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    155. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017 09; 49(9):1373-1384. Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould R, Bis JC, Martin ER, Grenier-Boley B, Heilmann-Heimbach S, Chouraki V, Kuzma AB, Sleegers K, Vronskaya M, Ruiz A, Graham RR, Olaso R, Hoffmann P, Grove ML, Vardarajan BN, Hiltunen M, Nöthen MM, White CC, Hamilton-Nelson KL, Epelbaum J, Maier W, Choi SH, Beecham GW, Dulary C, Herms S, Smith AV, Funk CC, Derbois C, Forstner AJ, Ahmad S, Li H, Bacq D, Harold D, Satizabal CL, Valladares O, Squassina A, Thomas R, Brody JA, Qu L, Sánchez-Juan P, Morgan T, Wolters FJ, Zhao Y, Garcia FS, Denning N, Fornage M, Malamon J, Naranjo MCD, Majounie E, Mosley TH, Dombroski B, Wallon D, Lupton MK, Dupuis J, Whitehead P, Fratiglioni L, Medway C, Jian X, Mukherjee S, Keller L, Brown K, Lin H, Cantwell LB, Panza F, McGuinness B, Moreno-Grau S, Burgess JD, Solfrizzi V, Proitsi P, Adams HH, Allen M, Seripa D, Pastor P, Cupples LA, Price ND, Hannequin D, Frank-García A, Levy D, Chakrabarty P, Caffarra P, Giegling I, Beiser AS, Giedraitis V, Hampel H, Garcia ME, Wang X, Lannfelt L, Mecocci P, Eiriksdottir G, Crane PK, Pasquier F, Boccardi V, Henández I, Barber RC, Scherer M, Tarraga L, Adams PM, Leber M, Chen Y, Albert MS, Riedel-Heller S, Emilsson V, Beekly D, Braae A, Schmidt R, Blacker D, Masullo C, Schmidt H, Doody RS, Spalletta G, Longstreth WT, Fairchild TJ, Bossù P, Lopez OL, Frosch MP, Sacchinelli E, Ghetti B, Yang Q, Huebinger RM, Jessen F, Li S, Kamboh MI, Morris J, Sotolongo-Grau O, Katz MJ, Corcoran C, Dunstan M, Braddel A, Thomas C, Meggy A, Marshall R, Gerrish A, Chapman J, Aguilar M, Taylor S, Hill M, Fairén MD, Hodges A, Vellas B, Soininen H, Kloszewska I, Daniilidou M, Uphill J, Patel Y, Hughes JT, Lord J, Turton J, Hartmann AM, Cecchetti R, Fenoglio C, Serpente M, Arcaro M, Caltagirone C, Orfei MD, Ciaramella A, Pichler S, Mayhaus M, Gu W, Lleó A, Fortea J, Blesa R, Barber IS, Brookes K, Cupidi C, Maletta RG, Carrell D, Sorbi S, Moebus S, Urbano M, Pilotto A, Kornhuber J, Bosco P, Todd S, Craig D, Johnston J, Gill M, Lawlor B, Lynch A, Fox NC, Hardy J, ARUK Consortium, Albin RL, Apostolova LG, Arnold SE, Asthana S, Atwood CS, Baldwin CT, Barnes LL, Barral S, Beach TG, Becker JT, Bigio EH, Bird TD, Boeve BF, Bowen JD, Boxer A, Burke JR, Burns JM, Buxbaum JD, Cairns NJ, Cao C, Carlson CS, Carlsson CM, Carney RM, Carrasquillo MM, Carroll SL, Diaz CC, Chui HC, Clark DG, Cribbs DH, Crocco EA, DeCarli C, Dick M, Duara R, Evans DA, Faber KM, Fallon KB, Fardo DW, Farlow MR, Ferris S, Foroud TM, Galasko DR, Gearing M, Geschwind DH, Gilbert JR, Graff-Radford NR, Green RC, Growdon JH, Hamilton RL, Harrell LE, Honig LS, Huentelman MJ, Hulette CM, Hyman BT, Jarvik GP, Abner E, Jin LW, Jun G, Karydas A, Kaye JA, Kim R, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lunetta KL, Lyketsos CG, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Morris JC, Murrell JR, Myers AJ, O'Bryant S, Olichney JM, Pankratz VS, Parisi JE, Paulson HL, Perry W, Peskind E, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reisberg B, Reitz C, Ringman JM, Roberson ED, Rogaeva E, Rosen HJ, Rosenberg RN, et al. PMID: 28714976; PMCID: PMC5669039.
      View in: PubMed   Mentions: 459     Fields:    Translation:HumansCells
    156. Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults. Alzheimers Res Ther. 2017 Jul 03; 9(1):48. Li G, Shofer JB, Petrie EC, Yu CE, Wilkinson CW, Figlewicz DP, Shutes-David A, Zhang J, Montine TJ, Raskind MA, Quinn JF, Galasko DR, Peskind ER. PMID: 28673336; PMCID: PMC5496132.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    157. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017 Jul 04; 89(1):88-100. McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K. PMID: 28592453; PMCID: PMC5496518.
      View in: PubMed   Mentions: 1289     Fields:    Translation:Humans
    158. A cerebrospinal fluid microRNA signature as biomarker for glioblastoma. Oncotarget. 2017 Sep 15; 8(40):68769-68779. Akers JC, Hua W, Li H, Ramakrishnan V, Yang Z, Quan K, Zhu W, Li J, Figueroa J, Hirshman BR, Miller B, Piccioni D, Ringel F, Komotar R, Messer K, Galasko DR, Hochberg F, Mao Y, Carter BS, Chen CC. PMID: 28978155; PMCID: PMC5620295.
      View in: PubMed   Mentions: 60     Fields:    
    159. Analysis of extracellular RNA in cerebrospinal fluid. J Extracell Vesicles. 2017; 6(1):1317577. Saugstad JA, Lusardi TA, Van Keuren-Jensen KR, Phillips JI, Lind B, Harrington CA, McFarland TJ, Courtright AL, Reiman RA, Yeri AS, Kalani MYS, Adelson PD, Arango J, Nolan JP, Duggan E, Messer K, Akers JC, Galasko DR, Quinn JF, Carter BS, Hochberg FH. PMID: 28717417; PMCID: PMC5505019.
      View in: PubMed   Mentions: 44     Fields:    
    160. Lewy Body Disorders. Neurol Clin. 2017 05; 35(2):325-338. Galasko D. PMID: 28410662; PMCID: PMC5912679.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    161. Searching for Neurodegeneration in the Blood of Patients With Alzheimer Disease. JAMA Neurol. 2017 05 01; 74(5):510-511. Galasko D. PMID: 28346580; PMCID: PMC5957497.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    162. Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease. Sci Rep. 2017 04 27; 7(1):1225. Müller S, Preische O, Sohrabi HR, Gräber S, Jucker M, Dietzsch J, Ringman JM, Martins RN, McDade E, Schofield PR, Ghetti B, Rossor M, Graff-Radford NR, Levin J, Galasko D, Quaid KA, Salloway S, Xiong C, Benzinger T, Buckles V, Masters CL, Sperling R, Bateman RJ, Morris JC, Laske C. PMID: 28450713; PMCID: PMC5430642.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    163. NPTX2 and cognitive dysfunction in Alzheimer's Disease. Elife. 2017 03 23; 6. Xiao MF, Xu D, Craig MT, Pelkey KA, Chien CC, Shi Y, Zhang J, Resnick S, Pletnikova O, Salmon D, Brewer J, Edland S, Wegiel J, Tycko B, Savonenko A, Reeves RH, Troncoso JC, McBain CJ, Galasko D, Worley PF. PMID: 28440221; PMCID: PMC5404919.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansAnimals
    164. Consensus classification of posterior cortical atrophy. Alzheimers Dement. 2017 Aug; 13(8):870-884. Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM, Dickerson BC, Vandenberghe R, Ahmed S, Bak TH, Boeve BF, Butler C, Cappa SF, Ceccaldi M, de Souza LC, Dubois B, Felician O, Galasko D, Graff-Radford J, Graff-Radford NR, Hof PR, Krolak-Salmon P, Lehmann M, Magnin E, Mendez MF, Nestor PJ, Onyike CU, Pelak VS, Pijnenburg Y, Primativo S, Rossor MN, Ryan NS, Scheltens P, Shakespeare TJ, Suárez González A, Tang-Wai DF, Yong KXX, Carrillo M, Fox NC, Alzheimer's Association ISTAART Atypical Alzheimer's Disease and Associated Syndromes Professional I. PMID: 28259709; PMCID: PMC5788455.
      View in: PubMed   Mentions: 213     Fields:    Translation:Humans
    165. Tau oligomers in cerebrospinal fluid in Alzheimer's disease. Ann Clin Transl Neurol. 2017 04; 4(4):226-235. Sengupta U, Portelius E, Hansson O, Farmer K, Castillo-Carranza D, Woltjer R, Zetterberg H, Galasko D, Blennow K, Kayed R. PMID: 28382304; PMCID: PMC5376754.
      View in: PubMed   Mentions: 37     Fields:    
    166. Mass-Spectrometry-Based Method To Quantify in Parallel Tau and Amyloid β 1-42 in CSF for the Diagnosis of Alzheimer's Disease. J Proteome Res. 2017 03 03; 16(3):1228-1238. Pottiez G, Yang L, Stewart T, Song N, Aro P, Galasko DR, Quinn JF, Peskind ER, Shi M, Zhang J. PMID: 28112948; PMCID: PMC5679294.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    167. Alzheimer disease: CSF biomarkers for Alzheimer disease - approaching consensus. Nat Rev Neurol. 2017 03; 13(3):131-132. Galasko DR, Shaw LM. PMID: 28155892; PMCID: PMC5912691.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    168. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study. J Prev Alzheimers Dis. 2017; 4(2):72-80. Kahle-Wrobleski K, Andrews JS, Belger M, Ye W, Gauthier S, Rentz DM, Galasko D. PMID: 29186278; PMCID: PMC5912689.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    169. Hippocampal α-Synuclein in Dementia with Lewy Bodies Contributes to Memory Impairment and Is Consistent with Spread of Pathology. J Neurosci. 2017 02 15; 37(7):1675-1684. Adamowicz DH, Roy S, Salmon DP, Galasko DR, Hansen LA, Masliah E, Gage FH. PMID: 28039370; PMCID: PMC5320602.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    170. Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1. Alzheimers Dement. 2017 Jun; 13(6):689-700. Cronin P, McCarthy MJ, Lim ASP, Salmon DP, Galasko D, Masliah E, De Jager PL, Bennett DA, Desplats P. PMID: 27883893; PMCID: PMC5785929.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    171. Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. PLoS One. 2016; 11(9):e0163669. Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N, Wang Q, Hornbeck RC, Ances BM, Snyder AZ, Cash LA, Koeppe RA, Klunk WE, Galasko D, Brickman AM, McDade E, Ringman JM, Thompson PM, Saykin AJ, Ghetti B, Sperling RA, Johnson KA, Salloway SP, Schofield PR, Masters CL, Villemagne VL, Fox NC, Förster S, Chen K, Reiman EM, Xiong C, Marcus DS, Weiner MW, Morris JC, Bateman RJ, Benzinger TL, Dominantly Inherited Alzheimer Network. PMID: 27649320; PMCID: PMC5029931.
      View in: PubMed   Mentions: 1     Fields:    
    172. Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies. Neurobiol Aging. 2017 01; 49:214.e13-214.e15. Kun-Rodrigues C, Ross OA, Orme T, Shepherd C, Parkkinen L, Darwent L, Hernandez D, Ansorge O, Clark LN, Honig LS, Marder K, Lemstra A, Scheltens P, van der Flier W, Louwersheimer E, Holstege H, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Holton J, Compta Y, Van Deerlin V, Trojanowski JQ, Serrano GE, Beach TG, Clarimon J, Lleó A, Morenas-Rodríguez E, Lesage S, Galasko D, Masliah E, Santana I, Diez M, Pastor P, Tienari PJ, Myllykangas L, Oinas M, Revesz T, Lees A, Boeve BF, Petersen RC, Ferman TJ, Escott-Price V, Graff-Radford N, Cairns NJ, Morris JC, Stone DJ, Pickering-Brown S, Mann D, Dickson DW, Halliday GM, Singleton A, Guerreiro R, Bras J. PMID: 27666590; PMCID: PMC5154872.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    173. Arguing against the proposed definition changes of PD. Mov Disord. 2016 11; 31(11):1619-1622. Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, Goldman JG, Growdon JH, Hurtig HI, Kaufer DI, Kantarci K, Leverenz JB, Lippa CF, Lopez OL, McKeith IG, Singleton AB, Taylor A, Tsuang D, Weintraub D, Zabetian CP. PMID: 27492190; PMCID: PMC5168716.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    174. Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies. Parkinsonism Relat Disord. 2016 10; 31:72-78. Peavy GM, Edland SD, Toole BM, Hansen LA, Galasko DR, Mayo AM. PMID: 27475955; PMCID: PMC5794000.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    175. Visual Perceptual Organization Ability in Autopsy-Verified Dementia with Lewy Bodies and Alzheimer's Disease. J Int Neuropsychol Soc. 2016 07; 22(6):609-19. Mitolo M, Hamilton JM, Landy KM, Hansen LA, Galasko D, Pazzaglia F, Salmon DP. PMID: 27221597; PMCID: PMC5802394.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    176. CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease. Alzheimers Dement. 2016 11; 12(11):1125-1131. Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, Yang L, Stewart T, Zheng D, Aro P, Atik A, Kerr KF, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Montine TJ, Banks WA, Zhang J. PMID: 27234211; PMCID: PMC5107127.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansAnimalsCells
    177. Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile. Alzheimers Dement (Amst). 2016; 3:63-72. Winston CN, Goetzl EJ, Akers JC, Carter BS, Rockenstein EM, Galasko D, Masliah E, Rissman RA. PMID: 27408937; PMCID: PMC4925777.
      View in: PubMed   Mentions: 176  
    178. "Missed" Mild Cognitive Impairment: High False-Negative Error Rate Based on Conventional Diagnostic Criteria. J Alzheimers Dis. 2016 03 31; 52(2):685-91. Edmonds EC, Delano-Wood L, Jak AJ, Galasko DR, Salmon DP, Bondi MW, Alzheimer’s Disease Neuroimaging Initiative. PMID: 27031477; PMCID: PMC4879874.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    179. CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study. Acta Neuropathol. 2016 06; 131(6):935-49. Kang JH, Mollenhauer B, Coffey CS, Toledo JB, Weintraub D, Galasko DR, Irwin DJ, Van Deerlin V, Chen-Plotkin AS, Caspell-Garcia C, Waligórska T, Taylor P, Shah N, Pan S, Zero P, Frasier M, Marek K, Kieburtz K, Jennings D, Tanner CM, Simuni T, Singleton A, Toga AW, Chowdhury S, Trojanowski JQ, Shaw LM, Parkinson’s Progression Marker Initiative. PMID: 27021906; PMCID: PMC5031365.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans
    180. Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group. PLoS One. 2016; 11(3):e0152082. Su Y, Blazey TM, Owen CJ, Christensen JJ, Friedrichsen K, Joseph-Mathurin N, Wang Q, Hornbeck RC, Ances BM, Snyder AZ, Cash LA, Koeppe RA, Klunk WE, Galasko D, Brickman AM, McDade E, Ringman JM, Thompson PM, Saykin AJ, Ghetti B, Sperling RA, Johnson KA, Salloway SP, Schofield PR, Masters CL, Villemagne VL, Fox NC, Förster S, Chen K, Reiman EM, Xiong C, Marcus DS, Weiner MW, Morris JC, Bateman RJ, Benzinger TL, Dominantly Inherited Alzheimer Network. PMID: 27010959; PMCID: PMC4807073.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    181. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease. Alzheimers Dement. 2016 08; 12(8):862-71. Schott JM, Crutch SJ, Carrasquillo MM, Uphill J, Shakespeare TJ, Ryan NS, Yong KX, Lehmann M, Ertekin-Taner N, Graff-Radford NR, Boeve BF, Murray ME, Khan QU, Petersen RC, Dickson DW, Knopman DS, Rabinovici GD, Miller BL, González AS, Gil-Néciga E, Snowden JS, Harris J, Pickering-Brown SM, Louwersheimer E, van der Flier WM, Scheltens P, Pijnenburg YA, Galasko D, Sarazin M, Dubois B, Magnin E, Galimberti D, Scarpini E, Cappa SF, Hodges JR, Halliday GM, Bartley L, Carrillo MC, Bras JT, Hardy J, Rossor MN, Collinge J, Fox NC, Mead S. PMID: 26993346; PMCID: PMC4982482.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    182. Expanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted Approaches. Front Neurol. 2015; 6:256. Galasko D. PMID: 26733934; PMCID: PMC4680926.
      View in: PubMed   Mentions: 9  
    183. Motion discrimination in dementia with Lewy bodies and Alzheimer disease. Neurology. 2015 Oct 20; 85(16):1376-82. Landy KM, Salmon DP, Galasko D, Filoteo JV, Festa EK, Heindel WC, Hansen LA, Hamilton JM. PMID: 26400581; PMCID: PMC4626245.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    184. Visual search in Dementia with Lewy Bodies and Alzheimer's disease. Cortex. 2015 Dec; 73:228-39. Landy KM, Salmon DP, Filoteo JV, Heindel WC, Galasko D, Hamilton JM. PMID: 26476402; PMCID: PMC4966887.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    185. Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans. Alzheimers Res Ther. 2015; 7(1):55. Ling IF, Golde TE, Galasko DR, Koo EH. PMID: 26244059; PMCID: PMC4523931.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    186. Recognition memory span in autopsy-confirmed Dementia with Lewy Bodies and Alzheimer's Disease. Neuropsychologia. 2015 Aug; 75:548-55. Salmon DP, Heindel WC, Hamilton JM, Vincent Filoteo J, Cidambi V, Hansen LA, Masliah E, Galasko D. PMID: 26184443; PMCID: PMC4752828.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    187. Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease. J Neuropathol Exp Neurol. 2015 Jul; 74(7):672-87. Yang Y, Keene CD, Peskind ER, Galasko DR, Hu SC, Cudaback E, Wilson AM, Li G, Yu CE, Montine KS, Zhang J, Baird GS, Hyman BT, Montine TJ. PMID: 26083568; PMCID: PMC4471879.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    188. Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase. Alzheimers Dement. 2016 Jan; 12(1):75-84. Gordon MF, Lenderking WR, Duhig A, Chandler J, Lundy JJ, Miller DS, Piault-Louis E, Doody RS, Galasko D, Gauthier S, Frank L, Patient-Reported Outcome Consortium's Cognition Working Group. PMID: 26079412.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    189. Encouraging trends toward reduced risk of Alzheimer disease: What's good for the heart is good for the brain. Neurol Clin Pract. 2015 Jun; 5(3):190-192. Breitner JCS, Galasko D. PMID: 29443188; PMCID: PMC5764461.
      View in: PubMed   Mentions: 1  
    190. Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults. JAMA Neurol. 2015 May; 72(5):546-53. Nation DA, Edmonds EC, Bangen KJ, Delano-Wood L, Scanlon BK, Han SD, Edland SD, Salmon DP, Galasko DR, Bondi MW, Alzheimer’s Disease Neuroimaging Initiative Investigators. PMID: 25822631; PMCID: PMC4428938.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    191. Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol. 2015 Feb; 72(2):209-16. Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, Tschanz JT, Munger RG, Corcoran CD, Rogaeva E, Alzheimer's Disease Genetics Consortium, Lin CF, Dombroski BA, Cantwell LB, Partch A, Valladares O, Hakonarson H, St George-Hyslop P, Green RC, Goate AM, Foroud TM, Carney RM, Larson EB, Behrens TW, Kauwe JS, Haines JL, Farrer LA, Pericak-Vance MA, Mayeux R, Schellenberg GD, National Institute on Aging-Late-Onset Alzheimer’s Disease (NIA-LOAD) Family Study, Albert MS, Albin RL, Apostolova LG, Arnold SE, Barber R, Barmada M, Barnes LL, Beach TG, Becker JT, Beecham GW, Beekly D, Bennett DA, Bigio EH, Bird TD, Blacker D, Boeve BF, Bowen JD, Boxer A, Burke JR, Buxbaum JD, Cairns NJ, Cao C, Carlson CS, Carroll SL, Chui HC, Clark DG, Cribbs DH, Crocco EA, DeCarli C, DeKosky ST, Demirci FY, Dick M, Dickson DW, Duara R, Ertekin-Taner N, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Glass JD, Graff-Radford NR, Growdon JH, Hamilton RL, Hamilton-Nelson KL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jarvik GP, Jicha GA, Jin LW, Jun G, Jun G, Kamboh MI, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lopez OL, Lunetta KL, Lyketsos CG, Mack WJ, Marson DC, Martin ER, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam WM, Miller BL, Miller CA, Miller JW, Montine TJ, Morris JC, Murrell JR, Olichney JM, Parisi JE, Perry W, Peskind E, Petersen RC, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reiman EM, Reisberg B, Reitz C, Ringman JM, Roberson ED, Rosen HJ, Rosenberg RN, Sano M, Saykin AJ, Schneider JA, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Tsuang DW, Van Deerlin VM, Van Eldik LJ, Vardarajan BN, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Wishnek S, Woltjer RL, Wright CB, Younkin SG, Yu CE, Yu L. PMID: 25531812; PMCID: PMC4324097.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    192. Clinical and Economic Characteristics of Milestones along the Continuum of Alzheimer's Disease: Transforming Functional Scores into Levels of Dependence. J Prev Alzheimers Dis. 2015; 2(2):115-120. Kahle-Wrobleski K, Andrews JS, Belger M, Gauthier S, Stern Y, Rentz DM, Galasko D. PMID: 28775969; PMCID: PMC5538012.
      View in: PubMed   Mentions: 4     Fields:    
    193. Cerebrospinal fluid peptides as potential Parkinson disease biomarkers: a staged pipeline for discovery and validation. Mol Cell Proteomics. 2015 Mar; 14(3):544-55. Shi M, Movius J, Dator R, Aro P, Zhao Y, Pan C, Lin X, Bammler TK, Stewart T, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Zhang J. PMID: 25556233; PMCID: PMC4349976.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    194. Increased CSF E-Selectin in Clinical Alzheimer's Disease without Altered CSF Aβ42 and Tau. J Alzheimers Dis. 2015; 47(4):883-7. Li G, Xiong K, Korff A, Pan C, Quinn JF, Galasko DR, Liu C, Montine TJ, Peskind ER, Zhang J. PMID: 26401768.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    195. Diagnostic Values of Cerebrospinal Fluid T-Tau and Aβ₄₂ using Meso Scale Discovery Assays for Alzheimer's Disease. J Alzheimers Dis. 2015; 45(3):709-19. Pan C, Korff A, Galasko D, Ginghina C, Peskind E, Li G, Quinn J, Montine TJ, Cain K, Shi M, Zhang J. PMID: 25613100; PMCID: PMC4517668.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    196. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease. J Alzheimers Dis. 2015; 47(1):231-42. Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW, Alzheimer’s Disease Neuroimaging Initiative. PMID: 26402771; PMCID: PMC4634634.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    197. Cerebrospinal fluid α-synuclein and Lewy body-like symptoms in normal controls, mild cognitive impairment, and Alzheimer's disease. J Alzheimers Dis. 2015; 43(3):1007-16. Mackin RS, Insel P, Zhang J, Mohlenhoff B, Galasko D, Weiner M, Mattsson N. PMID: 25125463; PMCID: PMC4350922.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    198. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. JAMA Neurol. 2014 Nov; 71(11):1394-404. Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, Baldwin CT, Jarvik GP, Crane PK, Rogaeva E, Barmada MM, Demirci FY, Cruchaga C, Kramer PL, Ertekin-Taner N, Hardy J, Graff-Radford NR, Green RC, Larson EB, St George-Hyslop PH, Buxbaum JD, Evans DA, Schneider JA, Lunetta KL, Kamboh MI, Saykin AJ, Reiman EM, De Jager PL, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Martin ER, Haines JL, Mayeux RP, Farrer LA, Schellenberg GD, Pericak-Vance MA, Alzheimer Disease Genetics Consortium, Albert MS, Albin RL, Apostolova LG, Arnold SE, Barber R, Barnes LL, Beach TG, Becker JT, Beekly D, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Cantwell LB, Cao C, Carlson CS, Carney RM, Carrasquillo MM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cribbs DH, Crocco EA, DeCarli C, DeKosky ST, Dick M, Dickson DW, Duara R, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lin CF, Lopez OL, Lyketsos CG, Mack WJ, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Murrell JR, Olichney JM, Pankratz VS, Parisi JE, Paulson HL, Peskind E, Petersen RC, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosen HJ, Rosenberg RN, Sano M, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Valladares O, Van Deerlin VM, Van Eldik LJ, Vardarajan BN, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Wishnek S, Woltjer RL, Wright CB, Younkin SG, Yu CE, Yu L. PMID: 25199842; PMCID: PMC4314944.
      View in: PubMed   Mentions: 98     Fields:    Translation:Humans
    199. Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials. Alzheimers Dement. 2015 Sep; 11(9):1069-79. Donohue MC, Moghadam SH, Roe AD, Sun CK, Edland SD, Thomas RG, Petersen RC, Sano M, Galasko D, Aisen PS, Rissman RA. PMID: 25301682; PMCID: PMC4387108.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    200. Influence of lifestyle modifications on age-related free radical injury to brain. JAMA Neurol. 2014 Sep; 71(9):1150-4. Peskind ER, Li G, Shofer JB, Millard SP, Leverenz JB, Yu CE, Raskind MA, Quinn JF, Galasko DR, Montine TJ. PMID: 25048271; PMCID: PMC4160350.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    201. Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment. J Int Neuropsychol Soc. 2014 Sep; 20(8):836-47. Edmonds EC, Delano-Wood L, Galasko DR, Salmon DP, Bondi MW, Alzheimer’s Disease Neuroimaging Initiative. PMID: 25156329; PMCID: PMC4172502.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    202. Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's disease. Alzheimers Dement. 2015 Apr; 11(4):394-403.e1. Bangen KJ, Nation DA, Delano-Wood L, Weissberger GH, Hansen LA, Galasko DR, Salmon DP, Bondi MW. PMID: 25022538; PMCID: PMC4287462.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    203. Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease. Acta Neuropathol. 2014 Nov; 128(5):639-650. Shi M, Liu C, Cook TJ, Bullock KM, Zhao Y, Ginghina C, Li Y, Aro P, Dator R, He C, Hipp MJ, Zabetian CP, Peskind ER, Hu SC, Quinn JF, Galasko DR, Banks WA, Zhang J. PMID: 24997849; PMCID: PMC4201967.
      View in: PubMed   Mentions: 288     Fields:    Translation:HumansAnimalsCells
    204. Targeted discovery and validation of plasma biomarkers of Parkinson's disease. J Proteome Res. 2014 Nov 07; 13(11):4535-45. Pan C, Zhou Y, Dator R, Ginghina C, Zhao Y, Movius J, Peskind E, Zabetian CP, Quinn J, Galasko D, Stewart T, Shi M, Zhang J. PMID: 24853996; PMCID: PMC4224986.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    205. Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span. JAMA Neurol. 2014 Jun; 71(6):742-51. Li G, Millard SP, Peskind ER, Zhang J, Yu CE, Leverenz JB, Mayer C, Shofer JS, Raskind MA, Quinn JF, Galasko DR, Montine TJ. PMID: 24756381; PMCID: PMC4051849.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    206. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. Lancet Neurol. 2014 Jun; 13(6):614-29. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, Galasko D, Habert MO, Jicha GA, Nordberg A, Pasquier F, Rabinovici G, Robert P, Rowe C, Salloway S, Sarazin M, Epelbaum S, de Souza LC, Vellas B, Visser PJ, Schneider L, Stern Y, Scheltens P, Cummings JL. PMID: 24849862.
      View in: PubMed   Mentions: 1285     Fields:    Translation:Humans
    207. Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors. Alzheimers Dement. 2015 Apr; 11(4):415-24. Edmonds EC, Delano-Wood L, Clark LR, Jak AJ, Nation DA, McDonald CR, Libon DJ, Au R, Galasko D, Salmon DP, Bondi MW, Alzheimer's Disease Neuroimaging Initiative. PMID: 24857234; PMCID: PMC4241187.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    208. Alzheimer's Disease Cooperative Study Prevention Instrument Project assessing resource use and volunteer and paid work in healthy elders: a longitudinal study. J Am Geriatr Soc. 2014 May; 62(5):985-8. Zhu CW, Sano M, Ferris SH, Whitehouse PJ, Patterson MB, Galasko D, Schneider LS, Aisen PS. PMID: 24828933; PMCID: PMC4023903.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    209. PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders. BMC Neurol. 2014 Apr 09; 14:79. Siderowf A, Pontecorvo MJ, Shill HA, Mintun MA, Arora A, Joshi AD, Lu M, Adler CH, Galasko D, Liebsack C, Skovronsky DM, Sabbagh MN. PMID: 24716655; PMCID: PMC4027995.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    210. Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease. Neurology. 2014 Apr 29; 82(17):1536-42. Galasko D, Bell J, Mancuso JY, Kupiec JW, Sabbagh MN, van Dyck C, Thomas RG, Aisen PS, Alzheimer's Disease Cooperative Study. PMID: 24696507; PMCID: PMC4011464.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansCTClinical Trials
    211. Effect of knowledge of APOE genotype on subjective and objective memory performance in healthy older adults. Am J Psychiatry. 2014 Feb; 171(2):201-8. Lineweaver TT, Bondi MW, Galasko D, Salmon DP. PMID: 24170170; PMCID: PMC4037144.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    212. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol. 2014 Mar; 127(3):407-18. Gallagher MD, Suh E, Grossman M, Elman L, McCluskey L, Van Swieten JC, Al-Sarraj S, Neumann M, Gelpi E, Ghetti B, Rohrer JD, Halliday G, Van Broeckhoven C, Seilhean D, Shaw PJ, Frosch MP, Alafuzoff I, Antonell A, Bogdanovic N, Brooks W, Cairns NJ, Cooper-Knock J, Cotman C, Cras P, Cruts M, De Deyn PP, DeCarli C, Dobson-Stone C, Engelborghs S, Fox N, Galasko D, Gearing M, Gijselinck I, Grafman J, Hartikainen P, Hatanpaa KJ, Highley JR, Hodges J, Hulette C, Ince PG, Jin LW, Kirby J, Kofler J, Kril J, Kwok JB, Levey A, Lieberman A, Llado A, Martin JJ, Masliah E, McDermott CJ, McKee A, McLean C, Mead S, Miller CA, Miller J, Munoz DG, Murrell J, Paulson H, Piguet O, Rossor M, Sanchez-Valle R, Sano M, Schneider J, Silbert LC, Spina S, van der Zee J, Van Langenhove T, Warren J, Wharton SB, White CL, Woltjer RL, Trojanowski JQ, Lee VM, Van Deerlin V, Chen-Plotkin AS. PMID: 24442578; PMCID: PMC4003885.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCells
    213. Effect of TTP488 in patients with mild to moderate Alzheimer's disease. BMC Neurol. 2014 Jan 15; 14:12. Burstein AH, Grimes I, Galasko DR, Aisen PS, Sabbagh M, Mjalli AM. PMID: 24423155; PMCID: PMC4021072.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCTClinical Trials
    214. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis. 2014; 42(1):275-89. Bondi MW, Edmonds EC, Jak AJ, Clark LR, Delano-Wood L, McDonald CR, Nation DA, Libon DJ, Au R, Galasko D, Salmon DP. PMID: 24844687; PMCID: PMC4133291.
      View in: PubMed   Mentions: 304     Fields:    Translation:HumansCells
    215. The new Qualitative Scoring MMSE Pentagon Test (QSPT) as a valid screening tool between autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease. J Alzheimers Dis. 2014; 39(4):823-32. Mitolo M, Salmon DP, Gardini S, Galasko D, Grossi E, Caffarra P. PMID: 24284368; PMCID: PMC4346244.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    216. Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease. PLoS One. 2013; 8(12):e85443. Mattsson N, Insel P, Tosun D, Zhang J, Jack CR, Galasko D, Weiner M, Alzheimer’s Disease Neuroimaging Initiative. PMID: 24392009; PMCID: PMC3877372.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    217. Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96. Eur J Neurosci. 2014 Mar; 39(6):1026-1041. Ubhi K, Rockenstein E, Kragh C, Inglis C, Spencer B, Michael S, Mante M, Adame A, Galasko D, Masliah E. PMID: 24304186; PMCID: PMC4052839.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    218. Pulse pressure is associated with Alzheimer biomarkers in cognitively normal older adults. Neurology. 2013 Dec 03; 81(23):2024-7. Nation DA, Edland SD, Bondi MW, Salmon DP, Delano-Wood L, Peskind ER, Quinn JF, Galasko DR. PMID: 24225352; PMCID: PMC3854831.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    219. Abnormal P600 word repetition effect in elderly persons with preclinical Alzheimer's disease. Cogn Neurosci. 2013; 4(3-4):143-51. Olichney JM, Pak J, Salmon DP, Yang JC, Gahagan T, Nowacki R, Hansen L, Galasko D, Kutas M, Iragui-Madoz VJ. PMID: 24090465; PMCID: PMC3841188.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    220. Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects. Neurobiol Aging. 2014 Feb; 35(2):357-64. Millard SP, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang D, Yu CE, Peskind ER, Bekris LM. PMID: 24011543; PMCID: PMC3859300.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    221. Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics. 2013 Oct; 8(10):1030-8. Masliah E, Dumaop W, Galasko D, Desplats P. PMID: 23907097; PMCID: PMC3891683.
      View in: PubMed   Mentions: 137     Fields:    Translation:HumansCells
    222. Accounting for functional loss in Alzheimer's disease and dementia with Lewy bodies: beyond cognition. Alzheimers Dement. 2014 Mar; 10(2):171-8. Hamilton JM, Salmon DP, Raman R, Hansen LA, Masliah E, Peavy GM, Galasko D. PMID: 23850331; PMCID: PMC4339266.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    223. C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complex. JAMA Neurol. 2013 Jun; 70(6):742-5. Dombroski BA, Galasko DR, Mata IF, Zabetian CP, Craig UK, Garruto RM, Oyanagi K, Schellenberg GD. PMID: 23588498; PMCID: PMC3771869.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    224. Progress in Alzheimer's disease research circa 2013: Is the glass half empty or half full? Alzheimers Res Ther. 2013; 5(3):26. Galasko D, Golde TE, Scheltens P. PMID: 23731836; PMCID: PMC3706787.
      View in: PubMed   Mentions: 1     Fields:    
    225. Interrater reliability of the new criteria for behavioral variant frontotemporal dementia. Neurology. 2013 May 21; 80(21):1973-7. Lamarre AK, Rascovsky K, Bostrom A, Toofanian P, Wilkins S, Sha SJ, Perry DC, Miller ZA, Naasan G, Laforce R, Hagen J, Takada LT, Tartaglia MC, Kang G, Galasko D, Salmon DP, Farias ST, Kaur B, Olichney JM, Quitania Park L, Mendez MF, Tsai PH, Teng E, Dickerson BC, Domoto-Reilly K, McGinnis S, Miller BL, Kramer JH. PMID: 23635967; PMCID: PMC3716343.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    226. Cerebrospinal fluid norepinephrine and cognition in subjects across the adult age span. Neurobiol Aging. 2013 Oct; 34(10):2287-92. Wang LY, Murphy RR, Hanscom B, Li G, Millard SP, Petrie EC, Galasko DR, Sikkema C, Raskind MA, Wilkinson CW, Peskind ER. PMID: 23639207; PMCID: PMC3706572.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    227. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron. 2013 Apr 24; 78(2):256-68. Cruchaga C, Kauwe JS, Harari O, Jin SC, Cai Y, Karch CM, Benitez BA, Jeng AT, Skorupa T, Carrell D, Bertelsen S, Bailey M, McKean D, Shulman JM, De Jager PL, Chibnik L, Bennett DA, Arnold SE, Harold D, Sims R, Gerrish A, Williams J, Van Deerlin VM, Lee VM, Shaw LM, Trojanowski JQ, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD, Peskind ER, Galasko D, Fagan AM, Holtzman DM, Morris JC, GERAD Consortium, Alzheimer’s Disease Neuroimaging Initiative (ADNI), Alzheimer Disease Genetic Consortium (ADGC), Goate AM. PMID: 23562540; PMCID: PMC3664945.
      View in: PubMed   Mentions: 216     Fields:    Translation:HumansCells
    228. Improved statistical power of Alzheimer clinical trials by item-response theory: proof of concept by application to the activities of daily living scale. Alzheimer Dis Assoc Disord. 2013 Apr-Jun; 27(2):187-91. Ard MC, Galasko DR, Edland SD. PMID: 22874658; PMCID: PMC4362713.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    229. The diagnostic evaluation of a patient with dementia. Continuum (Minneap Minn). 2013 Apr; 19(2 Dementia):397-410. Galasko D. PMID: 23558485; PMCID: PMC10563933.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    230. Neuropsychiatric features of frontal lobe dysfunction in autopsy-confirmed patients with lewy bodies and "pure" Alzheimer disease. Am J Geriatr Psychiatry. 2013 Jun; 21(6):509-19. Peavy GM, Salmon DP, Edland SD, Tam S, Hansen LA, Masliah E, Galasko D, Hamilton JM. PMID: 23567425; PMCID: PMC3664517.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    231. Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems. Alzheimers Res Ther. 2013; 5(2):10. Galasko D, Golde TE. PMID: 23470193; PMCID: PMC3706797.
      View in: PubMed   Mentions: 32     Fields:    
    232. APOE ε4 increases risk for dementia in pure synucleinopathies. JAMA Neurol. 2013 Feb; 70(2):223-8. Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Trojanowski JQ, Weintraub D, Chen-Plotkin AS, Irwin DJ, Rick J, Schellenberg GD, Watson GS, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Quinn JF, Chung KA, Yearout D, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP. PMID: 23407718; PMCID: PMC3580799.
      View in: PubMed   Mentions: 183     Fields:    Translation:HumansCells
    233. Antioxidants for Alzheimer disease-reply. JAMA Neurol. 2013 Feb; 70(2):270-1. Galasko DR, Aisen P. PMID: 23400724.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    234. Temporal sequence learning in healthy aging and amnestic mild cognitive impairment. Exp Aging Res. 2013; 39(4):371-81. Pirogovsky E, Holden HM, Jenkins C, Peavy GM, Salmon DP, Galasko DR, Gilbert PE. PMID: 23875836; PMCID: PMC3736698.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    235. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology. 2012 Nov 06; 79(19):1944-50. Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, Buchman AS, Larson EB, Crane PK, Kaye JA, Kramer P, Woltjer R, Kukull W, Nelson PT, Jicha GA, Neltner JH, Galasko D, Masliah E, Trojanowski JQ, Schellenberg GD, Yearout D, Huston H, Fritts-Penniman A, Mata IF, Wan JY, Edwards KL, Montine TJ, Zabetian CP. PMID: 23035075; PMCID: PMC3484986.
      View in: PubMed   Mentions: 81     Fields:    Translation:Humans
    236. Potential use of γ-secretase modulators in the treatment of Alzheimer disease. Arch Neurol. 2012 Oct; 69(10):1255-8. Wagner SL, Tanzi RE, Mobley WC, Galasko D. PMID: 22801784; PMCID: PMC3747667.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    237. Walking stabilizes cognitive functioning in Alzheimer's disease (AD) across one year. Arch Gerontol Geriatr. 2013 Jan-Feb; 56(1):96-103. Winchester J, Dick MB, Gillen D, Reed B, Miller B, Tinklenberg J, Mungas D, Chui H, Galasko D, Hewett L, Cotman CW. PMID: 22959822; PMCID: PMC3766353.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    238. Early visuospatial deficits predict the occurrence of visual hallucinations in autopsy-confirmed dementia with Lewy bodies. Am J Geriatr Psychiatry. 2012 Sep; 20(9):773-81. Hamilton JM, Landy KM, Salmon DP, Hansen LA, Masliah E, Galasko D. PMID: 21997600; PMCID: PMC3260388.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    239. Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2012 Oct; 159B(7):874-83. Bekris LM, Millard S, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang DW, Yu CE, Peskind ER. PMID: 22927204; PMCID: PMC3626266.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    240. Higher education is not associated with greater cortical thickness in brain areas related to literacy or intelligence in normal aging or mild cognitive impairment. J Clin Exp Neuropsychol. 2012; 34(9):925-35. Pillai JA, McEvoy LK, Hagler DJ, Holland D, Dale AM, Salmon DP, Galasko D, Fennema-Notestine C, Alzheimer's Disease Neuroimaging Initiative. PMID: 22905705; PMCID: PMC3488147.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    241. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol. 2012 Jul; 69(7):836-41. Galasko DR, Peskind E, Clark CM, Quinn JF, Ringman JM, Jicha GA, Cotman C, Cottrell B, Montine TJ, Thomas RG, Aisen P, Alzheimer’s Disease Cooperative Study. PMID: 22431837; PMCID: PMC3661272.
      View in: PubMed   Mentions: 159     Fields:    Translation:Humans
    242. The influence of chronic stress on dementia-related diagnostic change in older adults. Alzheimer Dis Assoc Disord. 2012 Jul-Sep; 26(3):260-6. Peavy GM, Jacobson MW, Salmon DP, Gamst AC, Patterson TL, Goldman S, Mills PJ, Khandrika S, Galasko D. PMID: 22037597; PMCID: PMC3290680.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    243. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology. 2012 Jul 17; 79(3):221-8. Allen M, Zou F, Chai HS, Younkin CS, Crook J, Pankratz VS, Carrasquillo MM, Rowley CN, Nair AA, Middha S, Maharjan S, Nguyen T, Ma L, Malphrus KG, Palusak R, Lincoln S, Bisceglio G, Georgescu C, Schultz D, Rakhshan F, Kolbert CP, Jen J, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD, Petersen RC, Graff-Radford NR, Dickson DW, Younkin SG, Ertekin-Taner N, Alzheimer's Disease Genetics Consortium (ADGC), Apostolova LG, Arnold SE, Baldwin CT, Barber R, Barmada MM, Beach T, Beecham GW, Beekly D, Bennett DA, Bigio EH, Bird TD, Blacker D, Boeve BF, Bowen JD, Boxer A, Burke JR, Buros J, Buxbaum JD, Cairns NJ, Cantwell LB, Cao C, Carlson CS, Carney RM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cotman CW, Crane PK, Cruchaga C, Cummings JL, De Jager PL, DeCarli C, DeKosky ST, Demirci FY, Diaz-Arrastia R, Dick M, Dombroski BA, Duara R, Ellis WD, Evans D, Faber KM, Fallon KB, Farlow MR, Ferris S, Foroud TM, Frosch M, Galasko DR, Gallins PJ, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Giordani B, Glass JD, Goate AM, Green RC, Growdon JH, Hakonarson H, Hamilton RL, Hardy J, Harrell LE, Head E, Honig LS, Huentelman MJ, Hulette CM, Hyman BT, Jarvik GP, Jicha GA, Jin LW, Jun G, Kamboh MI, Karlawish J, Karydas A, Kauwe JS, Kaye JA, Kennedy N, Kim R, Koo EH, Kowall NW, Kramer P, Kukull WA, Lah JJ, Larson EB, Levey AI, Lieberman AP, Lopez OL, Lunetta KL, Mack WJ, Marson DC, Martin ER, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Montine TJ, Morris JC, Myers AJ, Naj AC, Nowotny P, Parisi JE, Perl DP, Peskind E, Poon WW, Potter H, Quinn JF, Raj A, Rajbhandary RA, Raskind M, Reiman EM, Reisberg B, Reitz C, Ringman JM, Roberson ED, Rogaeva E, Rosenberg RN, Sano M, Saykin AJ, Schneider JA, Schneider LS, Seeley W, Shelanski ML, Slifer MA, Smith CD, Sonnen JA, Spina S, St George-Hyslop P, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Tsuang DW, Van Deerlin VM, Vardarajan BN, Vinters HV, Vonsattel JP, Wang LS, Weintraub S, Welsh-Bohmer KA, Williamson J, Woltjer RL. PMID: 22722634; PMCID: PMC3398432.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    244. Recent Alzheimer's disease research highlights. Alzheimers Res Ther. 2012 May 18; 4(3):14. Galasko D, Golde T, Wilcock G. PMID: 22594696; PMCID: PMC3506929.
      View in: PubMed   Mentions:    Fields:    
    245. ADAM10 expression and promoter haplotype in Alzheimer's disease. Neurobiol Aging. 2012 Sep; 33(9):2229.e1-2229.e9. Bekris LM, Lutz F, Li G, Galasko DR, Farlow MR, Quinn JF, Kaye JA, Leverenz JB, Tsuang DW, Montine TJ, Peskind ER, Yu CE. PMID: 22572541; PMCID: PMC3391324.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    246. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet. 2012 Aug 01; 21(15):3500-12. Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, Lee SE, Klein E, Huang AY, Sears R, Lane JR, Karydas AM, Kenet RO, Biernat J, Wang LS, Cotman CW, Decarli CS, Levey AI, Ringman JM, Mendez MF, Chui HC, Le Ber I, Brice A, Lupton MK, Preza E, Lovestone S, Powell J, Graff-Radford N, Petersen RC, Boeve BF, Lippa CF, Bigio EH, Mackenzie I, Finger E, Kertesz A, Caselli RJ, Gearing M, Juncos JL, Ghetti B, Spina S, Bordelon YM, Tourtellotte WW, Frosch MP, Vonsattel JP, Zarow C, Beach TG, Albin RL, Lieberman AP, Lee VM, Trojanowski JQ, Van Deerlin VM, Bird TD, Galasko DR, Masliah E, White CL, Troncoso JC, Hannequin D, Boxer AL, Geschwind MD, Kumar S, Mandelkow EM, Wszolek ZK, Uitti RJ, Dickson DW, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Alzheimer's Disease Genetics Consortium, Ross OA, Rademakers R, Schellenberg GD, Miller BL, Mandelkow E, Geschwind DH. PMID: 22556362; PMCID: PMC3392107.
      View in: PubMed   Mentions: 127     Fields:    Translation:Humans
    247. Incidence of new-onset seizures in mild to moderate Alzheimer disease. Arch Neurol. 2012 Mar; 69(3):368-72. Irizarry MC, Jin S, He F, Emond JA, Raman R, Thomas RG, Sano M, Quinn JF, Tariot PN, Galasko DR, Ishihara LS, Weil JG, Aisen PS. PMID: 22410444; PMCID: PMC3622046.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    248. Phosphorylated α-synuclein in Parkinson's disease. Sci Transl Med. 2012 Feb 15; 4(121):121ra20. Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VM, Siderowf AD, Hurtig H, Litvan I, Schiess MC, Peskind ER, Masuda M, Hasegawa M, Lin X, Pan C, Galasko D, Goldstein DS, Jensen PH, Yang H, Cain KC, Zhang J. PMID: 22344688; PMCID: PMC3302662.
      View in: PubMed   Mentions: 133     Fields:    Translation:HumansCells
    249. Detection of peri-synaptic amyloid-β pyroglutamate aggregates in early stages of Alzheimer's disease and in AβPP transgenic mice using a novel monoclonal antibody. J Alzheimers Dis. 2012; 28(4):783-94. Mandler M, Rockenstein E, Ubhi K, Hansen L, Adame A, Michael S, Galasko D, Santic R, Mattner F, Masliah E. PMID: 22064070; PMCID: PMC4350934.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    250. Antemortem pulse pressure elevation predicts cerebrovascular disease in autopsy-confirmed Alzheimer's disease. J Alzheimers Dis. 2012; 30(3):595-603. Nation DA, Delano-Wood L, Bangen KJ, Wierenga CE, Jak AJ, Hansen LA, Galasko DR, Salmon DP, Bondi MW. PMID: 22451309; PMCID: PMC3370943.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    251. Fractional synthesis and clearance rates for amyloid β. Nat Med. 2011 Oct 11; 17(10):1178-9; author reply 1179-80. Edland SD, Galasko DR. PMID: 21988985; PMCID: PMC7278268.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    252. Degree of bilingualism predicts age of diagnosis of Alzheimer's disease in low-education but not in highly educated Hispanics. Neuropsychologia. 2011 Dec; 49(14):3826-30. Gollan TH, Salmon DP, Montoya RI, Galasko DR. PMID: 22001315; PMCID: PMC3223277.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    253. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011 Aug 31; 477(7362):90-4. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Després S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray T. PMID: 21886162; PMCID: PMC3170097.
      View in: PubMed   Mentions: 856     Fields:    Translation:Animals
    254. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011 Sep; 134(Pt 9):2456-77. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EG, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, Miller BL. PMID: 21810890; PMCID: PMC3170532.
      View in: PubMed   Mentions: 1862     Fields:    Translation:Humans
    255. A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology. 2011 Aug 09; 77(6):556-63. Sano M, Bell KL, Galasko D, Galvin JE, Thomas RG, van Dyck CH, Aisen PS. PMID: 21795660; PMCID: PMC3149154.
      View in: PubMed   Mentions: 122     Fields:    Translation:Humans
    256. Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome. Mol Cell Proteomics. 2011 Oct; 10(10):M111.008862. Britschgi M, Rufibach K, Huang SL, Clark CM, Kaye JA, Li G, Peskind ER, Quinn JF, Galasko DR, Wyss-Coray T. PMID: 21742799; PMCID: PMC3205866.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    257. PF-04494700, an oral inhibitor of receptor for advanced glycation end products (RAGE), in Alzheimer disease. Alzheimer Dis Assoc Disord. 2011 Jul-Sep; 25(3):206-12. Sabbagh MN, Agro A, Bell J, Aisen PS, Schweizer E, Galasko D. PMID: 21192237; PMCID: PMC3346183.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    258. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement. 2011 Jul; 7(4):386-395.e6. Mattsson N, Andreasson U, Persson S, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, Coart E, Chiasserini D, Cutler N, Dahlfors G, Duller S, Fagan AM, Forlenza O, Frisoni GB, Galasko D, Galimberti D, Hampel H, Handberg A, Heneka MT, Herskovits AZ, Herukka SK, Holtzman DM, Humpel C, Hyman BT, Iqbal K, Jucker M, Kaeser SA, Kaiser E, Kapaki E, Kidd D, Klivenyi P, Knudsen CS, Kummer MP, Lui J, Lladó A, Lewczuk P, Li QX, Martins R, Masters C, McAuliffe J, Mercken M, Moghekar A, Molinuevo JL, Montine TJ, Nowatzke W, O'Brien R, Otto M, Paraskevas GP, Parnetti L, Petersen RC, Prvulovic D, de Reus HP, Rissman RA, Scarpini E, Stefani A, Soininen H, Schröder J, Shaw LM, Skinningsrud A, Skrogstad B, Spreer A, Talib L, Teunissen C, Trojanowski JQ, Tumani H, Umek RM, Van Broeck B, Vanderstichele H, Vecsei L, Verbeek MM, Windisch M, Zhang J, Zetterberg H, Blennow K. PMID: 21784349; PMCID: PMC3710290.
      View in: PubMed   Mentions: 150     Fields:    Translation:HumansCells
    259. Right sizing funding for Alzheimer's disease. Alzheimers Res Ther. 2011 May 06; 3(3):17. Golde TE, Lamb BT, Galasko D. PMID: 21554753; PMCID: PMC3226306.
      View in: PubMed   Mentions: 1     Fields:    
    260. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011 May; 43(5):436-41. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N, Younkin SG, Cruchaga C, Kauwe JS, Nowotny P, Kramer P, Hardy J, Huentelman MJ, Myers AJ, Barmada MM, Demirci FY, Baldwin CT, Green RC, Rogaeva E, St George-Hyslop P, Arnold SE, Barber R, Beach T, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Carlson CS, Carney RM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cotman CW, Cummings JL, DeCarli C, DeKosky ST, Diaz-Arrastia R, Dick M, Dickson DW, Ellis WG, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Giordani B, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Johnson N, Karlawish J, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Lah JJ, Levey AI, Lieberman AP, Lopez OL, Mack WJ, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Parisi JE, Perl DP, Peskind E, Petersen RC, Poon WW, Quinn JF, Rajbhandary RA, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosenberg RN, Sano M, Schneider LS, Seeley W, Shelanski ML, Slifer MA, Smith CD, Sonnen JA, Spina S, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Woltjer RL, Cantwell LB, Dombroski BA, Beekly D, Lunetta KL, Martin ER, Kamboh MI, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD. PMID: 21460841; PMCID: PMC3090745.
      View in: PubMed   Mentions: 1027     Fields:    Translation:Humans
    261. Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy. Am J Pathol. 2011 Apr; 178(4):1509-16. Wang Y, Hancock AM, Bradner J, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Edwards KL, Snapinn KW, Goldstein DS, Shi M, Zhang J. PMID: 21435440; PMCID: PMC3078443.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    262. Comparison of the memory performance index with standard neuropsychological measures of cognition. Am J Alzheimers Dis Other Demen. 2011 05; 26(3):235-9. Rafii MS, Taylor C, Coutinho A, Kim K, Galasko D. PMID: 21406427; PMCID: PMC3568924.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    263. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol. 2011 Mar; 69(3):570-80. Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, Wang Y, Aasly J, Goldstein D, Zhang J. PMID: 21400565; PMCID: PMC3117674.
      View in: PubMed   Mentions: 200     Fields:    Translation:HumansCells
    264. Global clinical dementia rating of 0.5 in MCI masks variability related to level of function. Neurology. 2011 Feb 15; 76(7):652-9. Chang YL, Bondi MW, McEvoy LK, Fennema-Notestine C, Salmon DP, Galasko D, Hagler DJ, Dale AM, Alzheimer's Disease Neuroimaging Initiative. PMID: 21321338; PMCID: PMC3053336.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    265. Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLoS One. 2011 Jan 12; 6(1):e16032. Perrin RJ, Craig-Schapiro R, Malone JP, Shah AR, Gilmore P, Davis AE, Roe CM, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, Kaye JA, Morris JC, Holtzman DM, Townsend RR, Fagan AM. PMID: 21264269; PMCID: PMC3020224.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    266. Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease. Neurobiol Aging. 2011 Mar; 32(3):556.e13-23. Bekris LM, Galloway NM, Millard S, Lockhart D, Li G, Galasko DR, Farlow MR, Clark CM, Quinn JF, Kaye JA, Schellenberg GD, Leverenz JB, Seubert P, Tsuang DW, Peskind ER, Yu CE. PMID: 21196064; PMCID: PMC3065534.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    267. CSF Aβ(42) and tau in Parkinson's disease with cognitive impairment. Mov Disord. 2010 Nov 15; 25(15):2682-5. Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko DR, Jankovic J, Zabetian CP, Leverenz JB, Zhang J. PMID: 20818673; PMCID: PMC2978754.
      View in: PubMed   Mentions: 95     Fields:    Translation:Humans
    268. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease. Biol Psychiatry. 2010 Nov 15; 68(10):903-12. Craig-Schapiro R, Perrin RJ, Roe CM, Xiong C, Carter D, Cairns NJ, Mintun MA, Peskind ER, Li G, Galasko DR, Clark CM, Quinn JF, D'Angelo G, Malone JP, Townsend RR, Morris JC, Fagan AM, Holtzman DM. PMID: 21035623; PMCID: PMC3011944.
      View in: PubMed   Mentions: 224     Fields:    Translation:HumansCells
    269. High normal fasting blood glucose is associated with dementia in Chinese elderly. Alzheimers Dement. 2010 Nov; 6(6):440-7. Mortimer JA, Borenstein AR, Ding D, Decarli C, Zhao Q, Copenhaver C, Guo Q, Chu S, Galasko D, Salmon DP, Dai Q, Wu Y, Petersen R, Hong Z. PMID: 21044774; PMCID: PMC2993007.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    270. SNCA variant associated with Parkinson disease and plasma alpha-synuclein level. Arch Neurol. 2010 Nov; 67(11):1350-6. Mata IF, Shi M, Agarwal P, Chung KA, Edwards KL, Factor SA, Galasko DR, Ginghina C, Griffith A, Higgins DS, Kay DM, Kim H, Leverenz JB, Quinn JF, Roberts JW, Samii A, Snapinn KW, Tsuang DW, Yearout D, Zhang J, Payami H, Zabetian CP. PMID: 21060011; PMCID: PMC3010848.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCells
    271. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 2010 Nov; 9(11):1118-27. Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P. PMID: 20934914.
      View in: PubMed   Mentions: 624     Fields:    Translation:Humans
    272. Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase. Arch Neurol. 2010 Oct; 67(10):1231-7. He J, Iosif AM, Lee DY, Martinez O, Chu S, Carmichael O, Mortimer JA, Zhao Q, Ding D, Guo Q, Galasko D, Salmon DP, Dai Q, Wu Y, Petersen RC, Hong Z, Borenstein AR, DeCarli C. PMID: 20937951; PMCID: PMC3051396.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    273. Functional evaluation distinguishes MCI patients from healthy elderly people--the ADCS/MCI/ADL scale. J Nutr Health Aging. 2010 Oct; 14(8):703-9. Pedrosa H, De Sa A, Guerreiro M, Maroco J, Simoes MR, Galasko D, de Mendonca A. PMID: 20922349.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    274. Neuropathology of dementia with Lewy bodies in advanced age: a comparison with Alzheimer disease. Neurosci Lett. 2010 Nov 26; 485(3):222-7. Ubhi K, Peng K, Lessig S, Estrella J, Adame A, Galasko D, Salmon DP, Hansen LA, Kawas CH, Masliah E. PMID: 20849919; PMCID: PMC2987680.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    275. SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's disease. PLoS Genet. 2010 Sep 16; 6(9):e1001101. Cruchaga C, Kauwe JS, Mayo K, Spiegel N, Bertelsen S, Nowotny P, Shah AR, Abraham R, Hollingworth P, Harold D, Owen MM, Williams J, Lovestone S, Peskind ER, Li G, Leverenz JB, Galasko D, Alzheimer's Disease Neuroimaging Initiative, Morris JC, Fagan AM, Holtzman DM, Goate AM. PMID: 20862329; PMCID: PMC2940763.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    276. Reduced hypocretin (orexin) levels in dementia with Lewy bodies. Neuroreport. 2010 Aug 04; 21(11):756-60. Lessig S, Ubhi K, Galasko D, Adame A, Pham E, Remidios K, Chang M, Hansen LA, Masliah E. PMID: 20531237; PMCID: PMC2908368.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    277. Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers. Neuromolecular Med. 2011 Mar; 13(1):37-43. Montine TJ, Peskind ER, Quinn JF, Wilson AM, Montine KS, Galasko D. PMID: 20632131; PMCID: PMC3000441.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    278. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins. FEBS J. 2010 Jul; 277(14):3051-67. Pham E, Crews L, Ubhi K, Hansen L, Adame A, Cartier A, Salmon D, Galasko D, Michael S, Savas JN, Yates JR, Glabe C, Masliah E. PMID: 20573181; PMCID: PMC2933033.
      View in: PubMed   Mentions: 121     Fields:    Translation:HumansAnimalsCells
    279. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Neurosci Lett. 2010 Aug 09; 480(1):78-82. Shi M, Zabetian CP, Hancock AM, Ginghina C, Hong Z, Yearout D, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Leverenz JB, Zhang J. PMID: 20540987; PMCID: PMC2943649.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCells
    280. Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study. Neurobiol Aging. 2011 Dec; 32(12):2113-22. Kramer PL, Xu H, Woltjer RL, Westaway SK, Clark D, Erten-Lyons D, Kaye JA, Welsh-Bohmer KA, Troncoso JC, Markesbery WR, Petersen RC, Turner RS, Kukull WA, Bennett DA, Galasko D, Morris JC, Ott J. PMID: 20452100; PMCID: PMC2990809.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    281. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS One. 2010 Feb 19; 5(2):e9313. Crews L, Spencer B, Desplats P, Patrick C, Paulino A, Rockenstein E, Hansen L, Adame A, Galasko D, Masliah E. PMID: 20174468; PMCID: PMC2824828.
      View in: PubMed   Mentions: 193     Fields:    Translation:HumansAnimalsCells
    282. DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain. 2010 Mar; 133(Pt 3):713-26. Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Leverenz JB, Baird G, Montine TJ, Hancock AM, Hwang H, Pan C, Bradner J, Kang UJ, Jensen PH, Zhang J. PMID: 20157014; PMCID: PMC2842513.
      View in: PubMed   Mentions: 285     Fields:    Translation:Humans
    283. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010 Mar; 42(3):234-9. Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, Arnold SE, Mann DM, Pickering-Brown SM, Seelaar H, Heutink P, van Swieten JC, Murrell JR, Ghetti B, Spina S, Grafman J, Hodges J, Spillantini MG, Gilman S, Lieberman AP, Kaye JA, Woltjer RL, Bigio EH, Mesulam M, Al-Sarraj S, Troakes C, Rosenberg RN, White CL, Ferrer I, Lladó A, Neumann M, Kretzschmar HA, Hulette CM, Welsh-Bohmer KA, Miller BL, Alzualde A, Lopez de Munain A, McKee AC, Gearing M, Levey AI, Lah JJ, Hardy J, Rohrer JD, Lashley T, Mackenzie IR, Feldman HH, Hamilton RL, Dekosky ST, van der Zee J, Kumar-Singh S, Van Broeckhoven C, Mayeux R, Vonsattel JP, Troncoso JC, Kril JJ, Kwok JB, Halliday GM, Bird TD, Ince PG, Shaw PJ, Cairns NJ, Morris JC, McLean CA, DeCarli C, Ellis WG, Freeman SH, Frosch MP, Growdon JH, Perl DP, Sano M, Bennett DA, Schneider JA, Beach TG, Reiman EM, Woodruff BK, Cummings J, Vinters HV, Miller CA, Chui HC, Alafuzoff I, Hartikainen P, Seilhean D, Galasko D, Masliah E, Cotman CW, Tuñón MT, Martínez MC, Munoz DG, Carroll SL, Marson D, Riederer PF, Bogdanovic N, Schellenberg GD, Hakonarson H, Trojanowski JQ, Lee VM. PMID: 20154673; PMCID: PMC2828525.
      View in: PubMed   Mentions: 294     Fields:    Translation:HumansCells
    284. Effects of apolipoprotein E-epsilon4 and -epsilon2 in amnestic mild cognitive impairment and dementia in Shanghai: SCOBHI-P. Am J Alzheimers Dis Other Demen. 2010 May; 25(3):233-8. Borenstein AR, Mortimer JA, Schellenberg GD, DeCarli C, Copenhaver C, Galasko D, Salmon DP, Petersen R. PMID: 20142627; PMCID: PMC2872993.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    285. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol. 2010 Feb; 67(2):161-70. Yu CE, Bird TD, Bekris LM, Montine TJ, Leverenz JB, Steinbart E, Galloway NM, Feldman H, Woltjer R, Miller CA, Wood EM, Grossman M, McCluskey L, Clark CM, Neumann M, Danek A, Galasko DR, Arnold SE, Chen-Plotkin A, Karydas A, Miller BL, Trojanowski JQ, Lee VM, Schellenberg GD, Van Deerlin VM. PMID: 20142524; PMCID: PMC2901991.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansCells
    286. Biomarkers of oxidative damage and inflammation in Alzheimer's disease. Biomark Med. 2010 Feb; 4(1):27-36. Galasko D, Montine TJ. PMID: 20383271; PMCID: PMC2850111.
      View in: PubMed   Mentions: 84     Fields:    Translation:Humans
    287. Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease. Mol Neurodegener. 2010 Jan 14; 5:2. Portelius E, Andreasson U, Ringman JM, Buerger K, Daborg J, Buchhave P, Hansson O, Harmsen A, Gustavsson MK, Hanse E, Galasko D, Hampel H, Blennow K, Zetterberg H. PMID: 20145736; PMCID: PMC2818651.
      View in: PubMed   Mentions: 40     Fields:    
    288. Effects of chronic stress on memory decline in cognitively normal and mildly impaired older adults. Am J Psychiatry. 2009 Dec; 166(12):1384-91. Peavy GM, Salmon DP, Jacobson MW, Hervey A, Gamst AC, Wolfson T, Patterson TL, Goldman S, Mills PJ, Khandrika S, Galasko D. PMID: 19755573; PMCID: PMC2864084.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    289. Parkinson-dementia complex and development of a new stable isotope dilution assay for BMAA detection in tissue. Toxicol Appl Pharmacol. 2009 Oct 15; 240(2):180-8. Snyder LR, Cruz-Aguado R, Sadilek M, Galasko D, Shaw CA, Montine TJ. PMID: 19716838; PMCID: PMC2753714.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    290. Welcome to Alzheimer's research & therapy. Alzheimers Res Ther. 2009 Jul 09; 1(1):1. Donnelly A, Galasko D, Golde T, Mulvany F, Wilcock G. PMID: 19671199; PMCID: PMC2719106.
      View in: PubMed   Mentions:    Fields:    
    291. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease. Proc Natl Acad Sci U S A. 2009 Jul 21; 106(29):12145-50. Britschgi M, Olin CE, Johns HT, Takeda-Uchimura Y, LeMieux MC, Rufibach K, Rajadas J, Zhang H, Tomooka B, Robinson WH, Clark CM, Fagan AM, Galasko DR, Holtzman DM, Jutel M, Kaye JA, Lemere CA, Leszek J, Li G, Peskind ER, Quinn JF, Yesavage JA, Ghiso JA, Wyss-Coray T. PMID: 19581601; PMCID: PMC2715538.
      View in: PubMed   Mentions: 87     Fields:    Translation:AnimalsCellsPHPublic Health
    292. Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates. Hum Mol Genet. 2009 Oct 01; 18(19):3725-38. Sieh W, Choi Y, Chapman NH, Craig UK, Steinbart EJ, Rothstein JH, Oyanagi K, Garruto RM, Bird TD, Galasko DR, Schellenberg GD, Wijsman EM. PMID: 19567404; PMCID: PMC2742398.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    293. Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings. Arch Neurol. 2009 May; 66(5):632-7. Petrie EC, Cross DJ, Galasko D, Schellenberg GD, Raskind MA, Peskind ER, Minoshima S. PMID: 19433663; PMCID: PMC2718788.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    294. Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS One. 2009; 4(5):e5424. Li G, Peskind ER, Millard SP, Chi P, Sokal I, Yu CE, Bekris LM, Raskind MA, Galasko DR, Montine TJ. PMID: 19412541; PMCID: PMC2671606.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    295. Lack of cerebral bmaa in human cerebral cortex. Neurology. 2009 Apr 14; 72(15):1360-1. Snyder LR, Cruz-Aguado R, Sadilek M, Galasko D, Shaw CA, Montine TJ. PMID: 19365059; PMCID: PMC2677491.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    296. A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease. Ann Clin Biochem. 2009 May; 46(Pt 3):235-40. Verwey NA, van der Flier WM, Blennow K, Clark C, Sokolow S, De Deyn PP, Galasko D, Hampel H, Hartmann T, Kapaki E, Lannfelt L, Mehta PD, Parnetti L, Petzold A, Pirttila T, Saleh L, Skinningsrud A, Swieten JC, Verbeek MM, Wiltfang J, Younkin S, Scheltens P, Blankenstein MA. PMID: 19342441.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    297. The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord. 2009 Apr-Jun; 23(2):91-101. Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, Cummings J, DeCarli C, Foster NL, Galasko D, Peskind E, Dietrich W, Beekly DL, Kukull WA, Morris JC. PMID: 19474567; PMCID: PMC2743984.
      View in: PubMed   Mentions: 512     Fields:    Translation:Humans
    298. Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. Arch Neurol. 2009 Apr; 66(4):448-57. Ma QL, Galasko DR, Ringman JM, Vinters HV, Edland SD, Pomakian J, Ubeda OJ, Rosario ER, Teter B, Frautschy SA, Cole GM. PMID: 19364929; PMCID: PMC2742778.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    299. Verbal learning and memory in patients with dementia with Lewy bodies or Parkinson's disease with dementia. J Clin Exp Neuropsychol. 2009 Oct; 31(7):823-34. Filoteo JV, Salmon DP, Schiehser DM, Kane AE, Hamilton JM, Rilling LM, Lucas JA, Zizak V, Galasko DR. PMID: 19221922; PMCID: PMC2935683.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    300. The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology. 2009 Feb 03; 72(5):473, 476; author reply 475-6. Borenstein AR, Mortimer JA, Schellenberg GD, Galasko D, McGeer PL, Steele JC. PMID: 19188582.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    301. Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid. J Alzheimers Dis. 2008 Nov; 15(3):409-17. Vuletic S, Li G, Peskind ER, Kennedy H, Marcovina SM, Leverenz JB, Petrie EC, Lee VM, Galasko D, Schellenberg GD, Albers JJ. PMID: 18997294; PMCID: PMC2667787.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    302. Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies. Neuropsychology. 2008 Nov; 22(6):729-37. Hamilton JM, Salmon DP, Galasko D, Raman R, Emond J, Hansen LA, Masliah E, Thal LJ. PMID: 18999346; PMCID: PMC2587484.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    303. Guest authorship, mortality reporting, and integrity in rofecoxib studies. JAMA. 2008 Aug 27; 300(8):901-2; author reply 904-6. Ferris S, Galasko D, Kirby L. PMID: 18728256.
      View in: PubMed   Mentions: 1     Fields:    
    304. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol. 2008 Sep; 7(9):812-26. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK, Potocnik F, Prince M, Stewart R, Wimo A, Zhang ZX, Antuono P, World Federation of Neurology Dementia Research Group. PMID: 18667359; PMCID: PMC2860610.
      View in: PubMed   Mentions: 389     Fields:    Translation:Humans
    305. Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria. Am J Geriatr Psychiatry. 2008 Jun; 16(6):469-77. Teng E, Ringman JM, Ross LK, Mulnard RA, Dick MB, Bartzokis G, Davies HD, Galasko D, Hewett L, Mungas D, Reed BR, Schneider LS, Segal-Gidan F, Yaffe K, Cummings JL, Alzheimer's Disease Research Centers of California-Depression in Alzheimer's Disease Investigators. PMID: 18515691; PMCID: PMC2989660.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    306. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement. 2008 May; 4(3):156-63. Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, Hyman B, Kuller L, Schenk D, Snyder S, Thomas RG, Tuszynski MH, Vellas B, Wurtman RJ, Snyder PJ, Frank RA, Albert M, Doody R, Ferris S, Kaye J, Koo E, Morrison-Bogorad M, Reisberg B, Salmon DP, Gilman S, Mohs R, Aisen PS, Breitner JC, Cummings JL, Kawas C, Phelps C, Poirier J, Sabbagh M, Touchon J, Khachaturian AS, Bain LJ. PMID: 18631960; PMCID: PMC2544623.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    307. Distinct cognitive profiles and rates of decline on the Mattis Dementia Rating Scale in autopsy-confirmed frontotemporal dementia and Alzheimer's disease. J Int Neuropsychol Soc. 2008 May; 14(3):373-83. Rascovsky K, Salmon DP, Hansen LA, Galasko D. PMID: 18419836; PMCID: PMC2864090.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    308. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 2008 May; 7(5):409-16. Van Deerlin VM, Leverenz JB, Bekris LM, Bird TD, Yuan W, Elman LB, Clay D, Wood EM, Chen-Plotkin AS, Martinez-Lage M, Steinbart E, McCluskey L, Grossman M, Neumann M, Wu IL, Yang WS, Kalb R, Galasko DR, Montine TJ, Trojanowski JQ, Lee VM, Schellenberg GD, Yu CE. PMID: 18396105; PMCID: PMC3546119.
      View in: PubMed   Mentions: 339     Fields:    Translation:Humans
    309. Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. J Alzheimers Dis. 2008 Apr; 13(3):255-66. Bekris LM, Millard SP, Galloway NM, Vuletic S, Albers JJ, Li G, Galasko DR, DeCarli C, Farlow MR, Clark CM, Quinn JF, Kaye JA, Schellenberg GD, Tsuang D, Peskind ER, Yu CE. PMID: 18430993; PMCID: PMC3192652.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    310. Primary care screening for dementia and mild cognitive impairment. JAMA. 2008 Mar 12; 299(10):1132; author reply 1133-4. Rafii MS, Galasko D. PMID: 18334686.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    311. Empiric refinement of the pathologic assessment of Lewy-related pathology in the dementia patient. Brain Pathol. 2008 Apr; 18(2):220-4. Leverenz JB, Hamilton R, Tsuang DW, Schantz A, Vavrek D, Larson EB, Kukull WA, Lopez O, Galasko D, Masliah E, Kaye J, Woltjer R, Clark C, Trojanowski JQ, Montine TJ. PMID: 18241240; PMCID: PMC2689097.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    312. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform. J Proteome Res. 2008 Feb; 7(2):720-30. Pan S, Rush J, Peskind ER, Galasko D, Chung K, Quinn J, Jankovic J, Leverenz JB, Zabetian C, Pan C, Wang Y, Oh JH, Gao J, Zhang J, Montine T, Zhang J. PMID: 18186601.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    313. The memory disorders clinic. Handb Clin Neurol. 2008; 89:107-12. Galasko D. PMID: 18631736.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    314. [ALS, Parkinson-Dementia complex and late-life dementia in the Chamorros Guam--an update]. Rinsho Shinkeigaku. 2007 Nov; 47(11):961. Galasko D. PMID: 18210848.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    315. Progressive impairment on neuropsychological tasks in a longitudinal study of preclinical Alzheimer's disease. Neuropsychology. 2007 Nov; 21(6):696-705. Mickes L, Wixted JT, Fennema-Notestine C, Galasko D, Bondi MW, Thal LJ, Salmon DP. PMID: 17983283.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    316. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med. 2007 Nov; 13(11):1359-62. Ray S, Britschgi M, Herbert C, Takeda-Uchimura Y, Boxer A, Blennow K, Friedman LF, Galasko DR, Jutel M, Karydas A, Kaye JA, Leszek J, Miller BL, Minthon L, Quinn JF, Rabinovici GD, Robinson WH, Sabbagh MN, So YT, Sparks DL, Tabaton M, Tinklenberg J, Yesavage JA, Tibshirani R, Wyss-Coray T. PMID: 17934472.
      View in: PubMed   Mentions: 425     Fields:    Translation:Humans
    317. Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals. Alzheimer Dis Assoc Disord. 2007 Oct-Dec; 21(4):292-9. Galasko DR, Graff-Radford N, May S, Hendrix S, Cottrell BA, Sagi SA, Mather G, Laughlin M, Zavitz KH, Swabb E, Golde TE, Murphy MP, Koo EH. PMID: 18090435.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    318. Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord. 2007 Oct-Dec; 21(4):S14-8. Rascovsky K, Hodges JR, Kipps CM, Johnson JK, Seeley WW, Mendez MF, Knopman D, Kertesz A, Mesulam M, Salmon DP, Galasko D, Chow TW, Decarli C, Hillis A, Josephs K, Kramer JH, Weintraub S, Grossman M, Gorno-Tempini ML, Miller BM. PMID: 18090417.
      View in: PubMed   Mentions: 111     Fields:    Translation:Humans
    319. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol. 2008 Jan; 115(1):133-45. Geser F, Winton MJ, Kwong LK, Xu Y, Xie SX, Igaz LM, Garruto RM, Perl DP, Galasko D, Lee VM, Trojanowski JQ. PMID: 17713769.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    320. Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy. Am J Pathol. 2007 Sep; 171(3):993-1002. Yang W, Woltjer RL, Sokal I, Pan C, Wang Y, Brodey M, Peskind ER, Leverenz JB, Zhang J, Perl DP, Galasko DR, Montine TJ. PMID: 17675576; PMCID: PMC1959487.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    321. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007 Aug; 6(8):734-46. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. PMID: 17616482.
      View in: PubMed   Mentions: 1367     Fields:    Translation:Humans
    322. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 2007 Sep; 114(3):221-9. Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, Woltjer R, Lopez OL, Hamilton R, Tsuang DW, Galasko D, Masliah E, Kaye J, Clark CM, Montine TJ, Lee VM, Trojanowski JQ. PMID: 17653732.
      View in: PubMed   Mentions: 219     Fields:    Translation:HumansCells
    323. Brain volumes in Guam dementia vs Parkinson dementia complex vs aging Chamorro adults. Neurology. 2007 Jul 10; 69(2):196-9. Kaye JA, Moore MM, Galasko D, Craig UK, Adonay R, Silbert LC. PMID: 17620553.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    324. The effects of prolonged stress and APOE genotype on memory and cortisol in older adults. Biol Psychiatry. 2007 Sep 01; 62(5):472-8. Peavy GM, Lange KL, Salmon DP, Patterson TL, Goldman S, Gamst AC, Mills PJ, Khandrika S, Galasko D. PMID: 17544378; PMCID: PMC2002507.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    325. Prevalence of dementia in Chamorros on Guam: relationship to age, gender, education, and APOE. Neurology. 2007 May 22; 68(21):1772-81. Galasko D, Salmon D, Gamst A, Olichney J, Thal LJ, Silbert L, Kaye J, Brooks P, Adonay R, Craig UK, Schellenberg G, Borenstein AR. PMID: 17515539.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    326. Cycad exposure and risk of dementia, MCI, and PDC in the Chamorro population of Guam. Neurology. 2007 May 22; 68(21):1764-71. Borenstein AR, Mortimer JA, Schofield E, Wu Y, Salmon DP, Gamst A, Olichney J, Thal LJ, Silbert L, Kaye J, Craig UL, Schellenberg GD, Galasko DR. PMID: 17515538.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsPHPublic Health
    327. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 2007 Mar 13; 68(11):812-9. Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, Growdon JH, Gwinn-Hardy KA, Hardy J, Heutink P, Iwatsubo T, Kosaka K, Lee VM, Leverenz JB, Masliah E, McKeith IG, Nussbaum RL, Olanow CW, Ravina BM, Singleton AB, Tanner CM, Trojanowski JQ, Wszolek ZK, DLB/PDD Working Group. PMID: 17353469.
      View in: PubMed   Mentions: 190     Fields:    Translation:Humans
    328. Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer's disease. Neuropsychology. 2007 Jan; 21(1):20-30. Rascovsky K, Salmon DP, Hansen LA, Thal LJ, Galasko D. PMID: 17201527.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    329. Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia. Hum Mol Genet. 2007 Feb 01; 16(3):295-306. Sundar PD, Yu CE, Sieh W, Steinbart E, Garruto RM, Oyanagi K, Craig UK, Bird TD, Wijsman EM, Galasko DR, Schellenberg GD. PMID: 17185385.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    330. Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid. J Alzheimers Dis. 2006 Dec; 10(4):399-406. Riekse RG, Li G, Petrie EC, Leverenz JB, Vavrek D, Vuletic S, Albers JJ, Montine TJ, Lee VM, Lee M, Seubert P, Galasko D, Schellenberg GD, Hazzard WR, Peskind ER. PMID: 17183151.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    331. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord. 2006 Oct-Dec; 20(4):210-6. Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, Foster NL, Galasko D, Graff-Radford N, Peskind ER, Beekly D, Ramos EM, Kukull WA. PMID: 17132964.
      View in: PubMed   Mentions: 569     Fields:    Translation:Humans
    332. ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trials. Alzheimer Dis Assoc Disord. 2006 Oct-Dec; 20(4 Suppl 3):S152-69. Galasko D, Bennett DA, Sano M, Marson D, Kaye J, Edland SD, Alzheimer's Disease Cooperative Study. PMID: 17135809.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansPHPublic Health
    333. ADCS Prevention Instrument Project: overview and initial results. Alzheimer Dis Assoc Disord. 2006 Oct-Dec; 20(4 Suppl 3):S109-23. Ferris SH, Aisen PS, Cummings J, Galasko D, Salmon DP, Schneider L, Sano M, Whitehouse PJ, Edland S, Thal LJ, Alzheimer's Disease Cooperative Study Group. PMID: 17135805.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansPHPublic Health
    334. Robert Katzman honored. Alzheimer Dis Assoc Disord. 2006 Jul-Sep; 20(3 Suppl 2):S27-8. Thal LJ, Kawas C, Galasko D, Salmon DP, Sundsmo MP. PMID: 16917190.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    335. Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. Arch Neurol. 2006 Jul; 63(7):936-9. Peskind ER, Li G, Shofer J, Quinn JF, Kaye JA, Clark CM, Farlow MR, DeCarli C, Raskind MA, Schellenberg GD, Lee VM, Galasko DR. PMID: 16831961.
      View in: PubMed   Mentions: 70     Fields:    Translation:Humans
    336. Characterization of tau pathologies in gray and white matter of Guam parkinsonism-dementia complex. Acta Neuropathol. 2006 May; 111(5):401-12. Winton MJ, Joyce S, Zhukareva V, Practico D, Perl DP, Galasko D, Craig U, Trojanowski JQ, Lee VM. PMID: 16609851.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    337. Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease. Mov Disord. 2006 Mar; 21(3):337-42. Janvin CC, Larsen JP, Salmon DP, Galasko D, Hugdahl K, Aarsland D. PMID: 16211595.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    338. The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Dis Assoc Disord. 2006 Jan-Mar; 20(1):6-15. Thal LJ, Kantarci K, Reiman EM, Klunk WE, Weiner MW, Zetterberg H, Galasko D, Praticò D, Griffin S, Schenk D, Siemers E. PMID: 16493230; PMCID: PMC1820855.
      View in: PubMed   Mentions: 90     Fields:    Translation:Humans
    339. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005 Dec 27; 65(12):1863-72. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M, Consortium on DLB. PMID: 16237129.
      View in: PubMed   Mentions: 1775     Fields:    Translation:HumansCells
    340. Safety and acceptability of the research lumbar puncture. Alzheimer Dis Assoc Disord. 2005 Oct-Dec; 19(4):220-5. Peskind ER, Riekse R, Quinn JF, Kaye J, Clark CM, Farlow MR, Decarli C, Chabal C, Vavrek D, Raskind MA, Galasko D. PMID: 16327349.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    341. Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC. Neurology. 2005 Sep 13; 65(5):768-9. Montine TJ, Li K, Perl DP, Galasko D. PMID: 16157919.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansPHPublic Health
    342. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology. 2005 Aug 09; 65(3):397-403. Rascovsky K, Salmon DP, Lipton AM, Leverenz JB, DeCarli C, Jagust WJ, Clark CM, Mendez MF, Tang-Wai DF, Graff-Radford NR, Galasko D. PMID: 16087904.
      View in: PubMed   Mentions: 58     Fields:    Translation:Humans
    343. Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease. J Int Neuropsychol Soc. 2005 Jul; 11(4):446-53. Galasko D, Schmitt F, Thomas R, Jin S, Bennett D, Alzheimer's Disease Cooperative Study. PMID: 16209425.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    344. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005 Jun 09; 352(23):2379-88. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ, Alzheimer's Disease Cooperative Study Group. PMID: 15829527.
      View in: PubMed   Mentions: 611     Fields:    Translation:HumansCTClinical Trials
    345. Biomarkers for Alzheimer's disease--clinical needs and application. J Alzheimers Dis. 2005 Mar; 8(4):339-46. Galasko D. PMID: 16556965.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansPHPublic Health
    346. Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World J Biol Psychiatry. 2005; 6(2):69-84. Wiltfang J, Lewczuk P, Riederer P, Grünblatt E, Hock C, Scheltens P, Hampel H, Vanderstichele H, Iqbal K, Galasko D, Lannfelt L, Otto M, Esselmann H, Henkel AW, Kornhuber J, Blennow K. PMID: 16156480.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    347. A comparison of episodic memory deficits in neuropathologically-confirmed Dementia with Lewy bodies and Alzheimer's disease. J Int Neuropsychol Soc. 2004 Sep; 10(5):689-97. Hamilton JM, Salmon DP, Galasko D, Delis DC, Hansen LA, Masliah E, Thomas RG, Thal LJ. PMID: 15327716.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    348. Role of LRP in TGFbeta2-mediated neuronal uptake of Abeta and effects on memory. J Neurosci Res. 2004 Jul 15; 77(2):217-28. Harris-White ME, Balverde Z, Lim GP, Kim P, Miller SA, Hammer H, Galasko D, Frautschy SA. PMID: 15211588.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    349. Galantamine maintains ability to perform activities of daily living in patients with Alzheimer's disease. J Am Geriatr Soc. 2004 Jul; 52(7):1070-6. Galasko D, Kershaw PR, Schneider L, Zhu Y, Tariot PN. PMID: 15209643.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    350. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004 Jan; 61(1):59-66. Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR, Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, Mintzer J, Zamrini EY, Cahn-Weiner D, Thal LJ, Alzheimer's Disease Cooperative Study. PMID: 14732621.
      View in: PubMed   Mentions: 315     Fields:    Translation:HumansCTClinical Trials
    351. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol. 2003 Dec; 60(12):1696-702. Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, Morris JC, McKeel DW, Farlow M, Weitlauf SL, Quinn J, Kaye J, Knopman D, Arai H, Doody RS, DeCarli C, Leight S, Lee VM, Trojanowski JQ. PMID: 14676043.
      View in: PubMed   Mentions: 151     Fields:    Translation:Humans
    352. Neuromotor abnormalities and risk for psychosis in Alzheimer's disease. Neurology. 2003 Oct 14; 61(7):954-8. Caligiuri MP, Peavy G, Salmon DP, Galasko DR, Thal LJ. PMID: 14557567.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    353. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2003 Sep; 74(9):1215-20. Aarsland D, Litvan I, Salmon D, Galasko D, Wentzel-Larsen T, Larsen JP. PMID: 12933921; PMCID: PMC1738667.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    354. Cerebrospinal fluid biomarkers in Alzheimer disease: a fractional improvement? Arch Neurol. 2003 Sep; 60(9):1195-6. Galasko D. PMID: 12975282.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    355. Abeta1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD. Neurology. 2003 Jul 22; 61(2):206-11. Masliah E, Alford M, Adame A, Rockenstein E, Galasko D, Salmon D, Hansen LA, Thal LJ. PMID: 12874400.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    356. Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. Neurobiol Aging. 2003 Jul-Aug; 24(4):521-36. Frank RA, Galasko D, Hampel H, Hardy J, de Leon MJ, Mehta PD, Rogers J, Siemers E, Trojanowski JQ, National Institute on Aging Biological Markers Working Group. PMID: 12714109.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansAnimals
    357. Insulin and Alzheimer's disease: an amyloid connection. Neurology. 2003 Jun 24; 60(12):1886-7. Galasko D. PMID: 12821727.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    358. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology. 2003 May 27; 60(10):1586-90. Merdes AR, Hansen LA, Jeste DV, Galasko D, Hofstetter CR, Ho GJ, Thal LJ, Corey-Bloom J. PMID: 12771246.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansCells
    359. Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease. Int J Psychophysiol. 2003 Feb; 47(2):95-115. Granholm E, Morris S, Galasko D, Shults C, Rogers E, Vukov B. PMID: 12568941.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    360. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol. 2003 Jan 15; 157(2):149-57. Plato CC, Garruto RM, Galasko D, Craig UK, Plato M, Gamst A, Torres JM, Wiederholt W. PMID: 12522022.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    361. Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. Neurology. 2002 Jun 25; 58(12):1801-8. Rascovsky K, Salmon DP, Ho GJ, Galasko D, Peavy GM, Hansen LA, Thal LJ. PMID: 12084880.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    362. Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. J Neurosci Res. 2002 May 01; 68(3):331-6. Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, Cole GM. PMID: 12111863.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    363. Effect of extrapyramidal signs and Lewy bodies on survival in patients with Alzheimer disease. Arch Neurol. 2002 Apr; 59(4):588-93. Haan MN, Jagust WJ, Galasko D, Kaye J. PMID: 11939893.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    364. ALS and PDC of Guam: forty-year follow-up. Neurology. 2002 Mar 12; 58(5):765-73. Plato CC, Galasko D, Garruto RM, Plato M, Gamst A, Craig UK, Torres JM, Wiederholt W. PMID: 11889241.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    365. Intracellular Abeta is increased by okadaic acid exposure in transfected neuronal and non-neuronal cell lines. Neurobiol Aging. 2002 Mar-Apr; 23(2):195-203. Sun X, Cole GM, Chu T, Xia W, Galasko D, Yamaguchi H, Tanemura K, Frautschy SA, Takashima A. PMID: 11804703.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    366. Clinical features and changing patterns of neurodegenerative disorders on Guam, 1997-2000. Neurology. 2002 Jan 08; 58(1):90-7. Galasko D, Salmon DP, Craig UK, Thal LJ, Schellenberg G, Wiederholt W. PMID: 11781411.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    367. No long-term effect of behavioral treatment on psychotropic drug use for agitation in Alzheimer's disease patients. J Geriatr Psychiatry Neurol. 2002; 15(2):95-8. Weiner MF, Tractenberg RE, Sano M, Logsdon R, Teri L, Galasko D, Gamst A, Thomas R, Thal LJ. PMID: 12083600.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    368. Cholinergic deficits in the brains of patients with parkinsonism-dementia complex of Guam. Neuroreport. 2001 Dec 21; 12(18):3901-3. Masliah E, Alford M, Galasko D, Salmon D, Hansen LA, Good PF, Perl DP, Thal L. PMID: 11742207.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    369. TAU as a susceptibility gene for amyotropic lateral sclerosis-parkinsonism dementia complex of Guam. Arch Neurol. 2001 Nov; 58(11):1871-8. Poorkaj P, Tsuang D, Wijsman E, Steinbart E, Garruto RM, Craig UK, Chapman NH, Anderson L, Bird TD, Plato CC, Perl DP, Weiderholt W, Galasko D, Schellenberg GD. PMID: 11708997.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    370. Rate of cognitive change in Alzheimer's disease: methodological approaches using random effects models. J Int Neuropsychol Soc. 2001 Nov; 7(7):813-24. Gould R, Abramson I, Galasko D, Salmon D. PMID: 11771624.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    371. Biological markers and the treatment of Alzheimer's disease. J Mol Neurosci. 2001 Oct; 17(2):119-25. Galasko D. PMID: 11816785.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    372. Lewy bodies and dementia. Curr Neurol Neurosci Rep. 2001 Sep; 1(5):435-41. Galasko D. PMID: 11898554.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    373. New approaches to diagnose and treat Alzheimer's disease: a glimpse of the future. Clin Geriatr Med. 2001 May; 17(2):393-410. Galasko D. PMID: 11375142.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsPHPublic Health
    374. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol. 2001 Mar; 58(3):383-7. Poorkaj P, Grossman M, Steinbart E, Payami H, Sadovnick A, Nochlin D, Tabira T, Trojanowski JQ, Borson S, Galasko D, Reich S, Quinn B, Schellenberg G, Bird TD. PMID: 11255441.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    375. Part V. Genetic advances and biological markers for Alzheimer's disease. Dis Mon. 2000 Nov; 46(11):731-43. Galasko DR. PMID: 11130324.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    376. Amyloid-beta and treatment opportunities for Alzheimer's disease. J Alzheimers Dis. 2000 Nov; 2(3-4):231-59. Sabbagh MN, Galasko D, Koo E, Thal LJ. PMID: 12214087.
      View in: PubMed   Mentions: 2     Fields:    
    377. Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study. Int J Geriatr Psychiatry. 2000 Sep; 15(9):794-802. Samuel W, Caligiuri M, Galasko D, Lacro J, Marini M, McClure FS, Warren K, Jeste DV. PMID: 10984725.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    378. Psychopathology at initial diagnosis in dementia with Lewy bodies versus Alzheimer disease: comparison of matched groups with autopsy-confirmed diagnoses. Int J Geriatr Psychiatry. 2000 Sep; 15(9):819-23. Rockwell E, Choure J, Galasko D, Olichney J, Jeste DV. PMID: 10984728.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    379. Measuring cognitive change in a cohort of patients with Alzheimer's disease. Stat Med. 2000 Jun 15-30; 19(11-12):1421-32. Galasko DR, Gould RL, Abramson IS, Salmon DP. PMID: 10844707.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    380. Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology. 2000 May 23; 54(10):1965-71. Paulsen JS, Salmon DP, Thal LJ, Romero R, Weisstein-Jenkins C, Galasko D, Hofstetter CR, Thomas R, Grant I, Jeste DV. PMID: 10822438.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    381. Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Their Role in Clinical Chemistry. EJIFCC. 2000 Mar; 12(1):11-20. Blennow K, Galasko D. PMID: 30675139; PMCID: PMC6341233.
      View in: PubMed   Mentions:
    382. Amyloid-beta peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma. Biochem Biophys Res Commun. 2000 Feb 24; 268(3):750-6. Kuo YM, Kokjohn TA, Kalback W, Luehrs D, Galasko DR, Chevallier N, Koo EH, Emmerling MR, Roher AE. PMID: 10679277.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCells
    383. Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture. J Neurochem. 1999 Dec; 73(6):2613-6. Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, Cole GM. PMID: 10582625.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    384. Effects of time and cholinesterase inhibitor treatment on multiple cerebrospinal fluid parameters in Alzheimer's disease. Methods Find Exp Clin Pharmacol. 1999 Oct; 21(8):549-54. Moriearty PL, Seubert P, Galasko D, Markwell S, Unni L, Vicari S, Becker RE. PMID: 10599054.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    385. Longitudinal stability of CSF tau levels in Alzheimer patients. Biol Psychiatry. 1999 Sep 15; 46(6):750-5. Sunderland T, Wolozin B, Galasko D, Levy J, Dukoff R, Bahro M, Lasser R, Motter R, Lehtimäki T, Seubert P. PMID: 10494442.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    386. Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol. 1999 Jul; 56(7):857-62. Clark CM, Sheppard L, Fillenbaum GG, Galasko D, Morris JC, Koss E, Mohs R, Heyman A. PMID: 10404988.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCTClinical Trials
    387. Rehabilitation of hemiparesis after stroke with a mirror. Lancet. 1999 Jun 12; 353(9169):2035-6. Altschuler EL, Wisdom SB, Stone L, Foster C, Galasko D, Llewellyn DM, Ramachandran VS. PMID: 10376620.
      View in: PubMed   Mentions: 139     Fields:    Translation:HumansCTClinical Trials
    388. Cerebrospinal fluid opens a window on Alzheimer disease. Arch Neurol. 1999 Jun; 56(6):655-6. Galasko D. PMID: 10369301.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    389. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease. Psychol Aging. 1999 Jun; 14(2):295-303. Bondi MW, Salmon DP, Galasko D, Thomas RG, Thal LJ. PMID: 10403716.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCTClinical Trials
    390. Retraction. Proc Natl Acad Sci U S A. 1998 09 29; 95(20):12069. Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD. PMID: 16578857; PMCID: PMC56067.
      View in: PubMed   Mentions: 2     Fields:    
    391. Cerebrospinal fluid tau protein is not elevated in HIV-associated neurologic disease in humans. HIV Neurobehavioral Research Center Group (HNRC). Neurosci Lett. 1998 Sep 18; 254(1):1-4. Ellis RJ, Seubert P, Motter R, Galasko D, Deutsch R, Heaton RK, Heyes MP, McCutchan JA, Atkinson JH, Grant I. PMID: 9780077.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    392. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet. 1998 Sep; 7(9):1511-6. Lambert JC, Berr C, Pasquier F, Delacourte A, Frigard B, Cottel D, Pérez-Tur J, Mouroux V, Mohr M, Cécyre D, Galasko D, Lendon C, Poirier J, Hardy J, Mann D, Amouyel P, Chartier-Harlin MC. PMID: 9700208.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    393. Prostaglandin E2 induced polymerization of human alpha-1-antichymotrypsin and suppressed its protease inhibitory activity: implications for Alzheimer's disease. Biochem Biophys Res Commun. 1998 Aug 10; 249(1):182-6. Licastro F, Davis LJ, Pedrini S, Galasko D, Masliah E. PMID: 9705853.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    394. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology. 1998 Aug; 51(2):351-7. Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ. PMID: 9710002.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansCTClinical Trials
    395. Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer disease. Arch Neurol. 1998 Jul; 55(7):994-1000. Connor DJ, Salmon DP, Sandy TJ, Galasko D, Hansen LA, Thal LJ. PMID: 9678318.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    396. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. Arch Neurol. 1998 Jul; 55(7):937-45. Galasko D, Chang L, Motter R, Clark CM, Kaye J, Knopman D, Thomas R, Kholodenko D, Schenk D, Lieberburg I, Miller B, Green R, Basherad R, Kertiles L, Boss MA, Seubert P. PMID: 9678311.
      View in: PubMed   Mentions: 120     Fields:    Translation:HumansCTClinical Trials
    397. The role of apolipoprotein E testing in the diagnosis of Alzheimer's disease. West J Med. 1998 Apr; 168(4):264-5. Galasko D. PMID: 9584668; PMCID: PMC1304955.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    398. CSF tau and Abeta42: logical biomarkers for Alzheimer's disease? Neurobiol Aging. 1998 Mar-Apr; 19(2):117-9. Galasko D. PMID: 9558144.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    399. Cerebrospinal fluid levels of A beta 42 and tau: potential markers of Alzheimer's disease. J Neural Transm Suppl. 1998; 53:209-21. Galasko D. PMID: 9700659.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    400. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. Hum Mol Genet. 1997 Nov; 6(12):2151-4. Lambert JC, Pérez-Tur J, Dupire MJ, Galasko D, Mann D, Amouyel P, Hardy J, Delacourte A, Chartier-Harlin MC. PMID: 9328480.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    401. The impact of apolipoprotein E4 on cause of death in Alzheimer's disease. Neurology. 1997 Jul; 49(1):76-81. Olichney JM, Sabbagh MN, Hofstetter CR, Galasko D, Grundman M, Katzman R, Thal LJ. PMID: 9222173.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    402. Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation. Ann Neurol. 1997 Jul; 42(1):124-8. Crook R, Ellis R, Shanks M, Thal LJ, Perez-Tur J, Baker M, Hutton M, Haltia T, Hardy J, Galasko D. PMID: 9225696.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    403. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc Natl Acad Sci U S A. 1997 Apr 29; 94(9):4526-31. Davis RE, Miller S, Herrnstadt C, Ghosh SS, Fahy E, Shinobu LA, Galasko D, Thal LJ, Beal MF, Howell N, Parker WD. PMID: 9114023; PMCID: PMC20756.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansCells
    404. Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology. 1997 Mar; 48(3):632-5. Galasko D, Clark C, Chang L, Miller B, Green RC, Motter R, Seubert P. PMID: 9065538.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    405. A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 2:S1-12. Ferris SH, Mackell JA, Mohs R, Schneider LS, Galasko D, Whitehouse PJ, Schmitt FA, Sano M, Thomas RG, Ernesto C, Grundman M, Schafer K, Thal LJ. PMID: 9236947.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    406. The tau protein in human cerebrospinal fluid in Alzheimer's disease consists of proteolytically derived fragments. J Neurochem. 1997 Jan; 68(1):430-3. Johnson GV, Seubert P, Cox TM, Motter R, Brown JP, Galasko D. PMID: 8978756.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    407. Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 2:S65-9. Mackell JA, Ferris SH, Mohs R, Schneider L, Galasko D, Whitehouse P, Schmitt F, Sano M, Thal LJ. PMID: 9236955.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    408. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997; 11 Suppl 2:S33-9. Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, Ferris S. PMID: 9236950.
      View in: PubMed   Mentions: 433     Fields:    Translation:HumansCTClinical Trials
    409. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996 Nov; 47(5):1113-24. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, de Vos RA, Wilcock GK, Jellinger KA, Perry RH. PMID: 8909416.
      View in: PubMed   Mentions: 819     Fields:    Translation:Humans
    410. ApoE and CYP2D6 polymorphism with and without parkinsonism-dementia complex in the people of Chamorro, guam. Neurology. 1996 Sep; 47(3):779-84. Chen X, Xia Y, Gresham LS, Molgaard CA, Thomas RG, Galasko D, Wiederholt WC, Saitoh T. PMID: 8797479.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    411. Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn. 1996 Jul; 31(2):148-65. Salmon DP, Galasko D, Hansen LA, Masliah E, Butters N, Thal LJ, Katzman R. PMID: 8811990.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    412. Clinical and neuropathological findings in Lewy body dementias. Brain Cogn. 1996 Jul; 31(2):166-75. Galasko D, Katzman R, Salmon DP, Hansen L. PMID: 8811993.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    413. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology. 1996 Jul; 47(1):190-6. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, Thal LJ. PMID: 8710076.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCells
    414. Neuropsychological assessment of severely demeted elderly: the severe cognitive impairment profile. Arch Neurol. 1996 Apr; 53(4):367-72. Peavy GM, Salmon DP, Rice VA, Galasko D, Samuel W, Taylor KI, Ernesto C, Butters N, Thal L. PMID: 8929160.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    415. Apolipoprotein-epsilon4 and head trauma: Synergistic or additive risks? Neurology. 1996 Mar; 46(3):889-91. Katzman R, Galasko DR, Saitoh T, Chen X, Pay MM, Booth A, Thomas RG. PMID: 8618734.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    416. Extrapyramidal motor signs in clinically diagnosed Alzheimer disease. Alzheimer Dis Assoc Disord. 1996; 10(2):103-14. Ellis RJ, Caligiuri M, Galasko D, Thal LJ. PMID: 8727172.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    417. Neocortical lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol. 1996 Jan; 55(1):44-52. Samuel W, Galasko D, Masliah E, Hansen LA. PMID: 8558171.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    418. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: A CERAD analysis, Part XII. Neurology. 1996 Jan; 46(1):136-41. Koss E, Edland S, Fillenbaum G, Mohs R, Clark C, Galasko D, Morris JC. PMID: 8559362.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    419. Lewy body dementia--diagnosis and treatment. Br J Psychiatry. 1995 Dec; 167(6):709-17. McKeith IG, Galasko D, Wilcock GK, Byrne EJ. PMID: 8829735.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    420. Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology. 1995 Dec; 45(12):2203-6. Bondi MW, Salmon DP, Monsch AU, Galasko D, Butters N, Klauber MR, Thal LJ, Saitoh T. PMID: 8848194.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    421. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol. 1995 Oct; 38(4):643-8. Motter R, Vigo-Pelfrey C, Kholodenko D, Barbour R, Johnson-Wood K, Galasko D, Chang L, Miller B, Clark C, Green R, et al. PMID: 7574461.
      View in: PubMed   Mentions: 164     Fields:    Translation:HumansCells
    422. Death certificate reporting of dementia and mortality in an Alzheimer's disease research center cohort. J Am Geriatr Soc. 1995 Aug; 43(8):890-3. Olichney JM, Hofstetter CR, Galasko D, Thal LJ, Katzman R. PMID: 7636097.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    423. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years. Neurology. 1995 Aug; 45(8):1451-5. Galasko D, Edland SD, Morris JC, Clark C, Mohs R, Koss E. PMID: 7644039.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    424. Adjunctive therapy in patients with Alzheimer's disease. A practical approach. Drugs Aging. 1995 Aug; 7(2):79-87. Corey-Bloom J, Galasko D. PMID: 7579786.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    425. Genetic evidence that the Lewy body variant is indeed a phenotypic variant of Alzheimer's disease. Brain Cogn. 1995 Aug; 28(3):259-65. Katzman R, Galasko D, Saitoh T, Thal LJ, Hansen L. PMID: 8546853.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    426. A fibroblast growth factor binding protein in human cerebral spinal fluid. Neuroreport. 1995 Apr 19; 6(6):886-8. Hanneken A, Frautschy S, Galasko D, Baird A. PMID: 7612876.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    427. Diagnosis and evaluation of dementia. Neurology. 1995 Feb; 45(2):211-8. Corey-Bloom J, Thal LJ, Galasko D, Folstein M, Drachman D, Raskind M, Lanska DJ. PMID: 7854514.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    428. The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease. Ann Neurol. 1995 Jan; 37(1):110-2. Saitoh T, Xia Y, Chen X, Masliah E, Galasko D, Shults C, Thal LJ, Hansen LA, Katzman R. PMID: 7818242.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    429. The spectrum of diseases with diffuse Lewy bodies. Adv Neurol. 1995; 65:159-70. Olichney JM, Galasko D, Corey-Bloom J, Thal LJ. PMID: 7872137.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    430. Apolipoprotein-E epsilon-4 is associated with increased neurofibrillary pathology in the Lewy body variant of Alzheimer's disease. Neurosci Lett. 1994 Nov 21; 182(1):63-5. Hansen LA, Galasko D, Samuel W, Xia Y, Chen X, Saitoh T. PMID: 7891889.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    431. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology. 1994 Oct; 44(10):1950-1. Galasko D, Saitoh T, Xia Y, Thal LJ, Katzman R, Hill LR, Hansen L. PMID: 7936253.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    432. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol. 1994 Sep; 51(9):888-95. Galasko D, Hansen LA, Katzman R, Wiederholt W, Masliah E, Terry R, Hill LR, Lessin P, Thal LJ. PMID: 8080388.
      View in: PubMed   Mentions: 92     Fields:    Translation:Humans
    433. Selective rubella vaccination programmes: a survey of districts in England and Wales. Commun Dis Rep CDR Rev. 1994 Jun 24; 4(7):R77-9. Gay NJ, Valambia S, Galasko D, Miller E. PMID: 7520802.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    434. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology. 1993 Dec; 43(12):2457-65. Morris JC, Edland S, Clark C, Galasko D, Koss E, Mohs R, van Belle G, Fillenbaum G, Heyman A. PMID: 8255439.
      View in: PubMed   Mentions: 106     Fields:    Translation:Humans
    435. Plaque-only Alzheimer disease is usually the lewy body variant, and vice versa. J Neuropathol Exp Neurol. 1993 Nov; 52(6):648-54. Hansen LA, Masliah E, Galasko D, Terry RD. PMID: 8229084.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    436. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology. 1993 Oct; 43(10):1927-34. Langlais PJ, Thal L, Hansen L, Galasko D, Alford M, Masliah E. PMID: 8105420.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    437. Repeated exposure to the Mini-Mental State Examination and the Information-Memory-Concentration Test results in a practice effect in Alzheimer's disease. Neurology. 1993 Aug; 43(8):1559-63. Galasko D, Abramson I, Corey-Bloom J, Thal LJ. PMID: 8351011.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    438. Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature. 1993 Jan 21; 361(6409):260-3. Seubert P, Oltersdorf T, Lee MG, Barbour R, Blomquist C, Davis DL, Bryant K, Fritz LC, Galasko D, Thal LJ, et al. PMID: 7678698.
      View in: PubMed   Mentions: 99     Fields:    Translation:HumansCells
    439. Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia. J Am Geriatr Soc. 1993 Jan; 41(1):31-7. Corey-Bloom J, Galasko D, Hofstetter CR, Jackson JE, Thal LJ. PMID: 8418119.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    440. Lewy body disease. Curr Opin Neurol Neurosurg. 1992 Dec; 5(6):889-94. Hansen LA, Galasko D. PMID: 1467583.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    441. Quantifying drug-induced changes in parkinsonian rigidity using an instrumental measure of activated stiffness. Clin Neuropharmacol. 1992 Feb; 15(1):1-12. Caligiuri MP, Galasko DR. PMID: 1576594.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    442. Monitoring progression in Alzheimer's disease. J Am Geriatr Soc. 1991 Sep; 39(9):932-41. Galasko D, Corey-Bloom J, Thal LJ. PMID: 1842209.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    443. Stimulated platelets release amyloid beta-protein precursor. Biochem Biophys Res Commun. 1990 Jul 16; 170(1):288-95. Cole GM, Galasko D, Shapiro IP, Saitoh T. PMID: 2115331; PMCID: PMC4019003.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    444. Neurological findings in Alzheimer's disease and normal aging. Arch Neurol. 1990 Jun; 47(6):625-7. Galasko D, Kwo-on-Yuen PF, Klauber MR, Thal LJ. PMID: 2346387.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    445. The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease. Arch Neurol. 1990 Jan; 47(1):49-52. Galasko D, Klauber MR, Hofstetter CR, Salmon DP, Lasker B, Thal LJ. PMID: 2294894.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    446. Lobar atrophy with dense-core (brain stem type) Lewy bodies in a patient with dementia. Acta Neuropathol. 1990; 80(4):453-8. Masliah E, Galasko D, Wiley CA, Hansen LA. PMID: 2173332.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    447. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology. 1990 Jan; 40(1):1-8. Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M, et al. PMID: 2153271.
      View in: PubMed   Mentions: 184     Fields:    Translation:HumansCells
    448. Intracranial mass lesions associated with late-onset psychosis and depression. Psychiatr Clin North Am. 1988 Mar; 11(1):151-66. Galasko D, Kwo-On-Yuen PF, Thal L. PMID: 3288979.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    449. Ataxic hemiparesis with intact sensory modalities. Arch Neurol. 1986 Jan; 43(1):8. Schleimer J, Galasko D, Stern BJ. PMID: 3942522.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Douglas's Networks
    Concepts (851)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (188)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California